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ABSTRACT 
Cancer is the second deadliest disease in the United States. Over 100 different 
types of cancers exist, among which lung, breast and prostate cancers are those most 
frequently diagnosed. Genetic factors are important. However, exposures to tobacco 
smoke and environmental pollutants are considered to be responsible for 75%–80% of 
cancer. About 6% of cancer deaths every year in the US are reportedly to be directly 
linked to known carcinogen exposures. Therefore, it is important to study the 
mechanisms of how the environmental carcinogens trigger cancer initiation. Most 
chemical carcinogens are metabolized into reactive species in vivo to interact with DNA, 
consequently producing covalent DNA adducts. These harmful lesions can be removed 
by various repair systems including base excision and nucleotide excision repair 
machinery in the cell. However, unrepaired lesions can enter into cell’s DNA replication 
cycle and generate various point and frameshift mutations. In particular, the latter 
represents a gain or loss of base pairs, which alters the genome information. As an 
example, mutations on the specific genes such as the tumor suppressor p53 may trigger 
cancer initiation.  
Arylamine is known as an important group of environmental chemical 
carcinogens.  Some members of this group, such as 4-aminobiphenyl (ABP), benzidine 
and 2-naphthylamine, are classified as human bladder carcinogens. These chemicals are 
found commonly in cigarette smoke, incomplete diesel exhausts, and hair dye products. 
2-Aminofluorene is a prototype animal carcinogen that undergoes metabolic activation by 
liver enzymes to form electrophilic nitrenium ion to form two major C8 substituted 
DNA-adducts: N-(2-deoxyguanosin-8-yl)-2-aminofluorene (dG-C8-AF) and N-(2-
  
 
deoxyguanosin-8-yl)-2-acetylaminofluorene (dG-C8-AAF). Similarly, the human 
carcinogen ABP produces N-(2-deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP). 
Encountering these lesions in a replicative or a bypass polymerase will result in different 
types of biological outcomes, such as error-free, error-prone, or frameshifts.     
Manuscript I (published in Chemical Research in Toxicology, 2012) is a rapid 
report. In this communication, we used a real-time, label-free chip-based technique 
named surface plasmon resonance (SPR) to determine the binding interaction between 
the DNA replicative polymerase exonuclease-free Klenow fragment and three arylamine 
DNA lesions (FAF/FAAF/FABP). We designed biotin labeled DNA hairpin construct 
with modified lesions and immobilized the DNA on the streptavidin coated chip. The 
analyte Kf-exo
-
 was added over the DNA surface in the presence or absence of dNTP. 
The results showed a tight binding between the enzyme and unmodified DNA with great 
dNTP selectivity.  In contrast, the dNTP selectivity was minimal in adduct modified 
DNA. Moreover, lesion included DNA tended to have better and stronger binding than 
unmodified DNA.  
Manuscript II (published in Chemical Research in Toxicology, 2014) contains 
the full details of Manuscript I. The full paper involves two 5’-flanking sequence 
(CG*A and TG*A), two adducts (FAAF and FABP), and two different polymerases (E. 
coli replicative polymerase Kf-exo
- 
and human repair polymerase ). We employed the 
same SPR methodology to study the binding interaction and complementary 
19
F NMR 
and primer steady-state kinetics. Results showed significant substrate specificity for Kf-
exo
- 
and polymerase , which are double-stranded/single-stranded junction and a double-
stranded DNA with a nucleotide gap structure, respectively. Tight binding with native 
  
 
DNA was observed, as well as the high nucleotide selectivity. However, Kf-exo
-
 binds 
tightly to lesion DNA, but not for polymerase . A minimal nucleotide selectivity for 
modified was observed with both enzymes. Moreover, the dynamic 
19
F NMR and primer 
steady-state kinetics results indicated the importance of lesion-induced conformational 
heterogeneity in polymerase binding.  
In Manuscript III (to be submitted to Journal of Molecular Biology), we 
conducted a series of systematic studies to probe the conformational mechanisms of 
arylamine-induced -2 base deletion mutations frequently observed in the NarI mutational 
hot sequence (5’---TCGGCG*CN---3’; N= dC and dT) of  E. coli during translesion 
synthesis (TLS). We employed two well-characterized fluorinated bulky DNA lesions 
FAAF and FABP that were derived from the environmental carcinogens 2-aminofluorene 
and 4-aminbiphenyl. Our work focused primarily on elucidating the effects of lesion size, 
bulkiness, and overall topology and the 3’-next flanking base N in producing the bulge 
structure responsible for -2 frameshift mutations. Two chemical simulated TLS models 
were examined, in which the FAAF/FABP lesion is positioned at G3 position of two 16-
mer NarI sequences, which were annealed systematically with increasing primer lengths 
in the full length and -2 deletion pathways. Their thermodynamic, conformational, and 
binding profiles at each elongation step were measured by various biophysical techniques 
including spectroscopic (dynamic 
19
F NMR/CD), thermodynamic (UV-melting/DSC), 
and affinity binding (SPR).  Results showed two different -2 bulge formations, which are 
triggered by the conformational stability of the G3*: C base pair at the replication fork, as 
well as the nature of base sequences surrounding the lesion site.  Each bulge structure 
exists in a mixture of “external solvent exposed” B-type (B-SMI) and “inserted solvent 
  
 
protected “stacked” S-type (S-SMI), and their conformational rigidity increases as a 
function of primer lengths. The results indicate the importance of conformational stability, 
heterogeneity, and flexibility in the mechanisms of bulky arylamine-induced frameshift 
mutagenesis.   
 vi 
 
ACKNOWLEDGEMENTS 
 
A completion of my doctoral program is the most significant milestone in my life. 
It would not be possible without the help and support from many people around me. First 
of all, I thank my major professor, Dr. Bongsup Cho, for giving me the opportunity to be 
his graduate student and for his guidance and encouragement during my program. 
Without his patience and immense support and input, this dissertation would not have 
been possible. He has been my mentor not just academically but also for my personal 
aspects. I am extremely grateful to learn so many things from him to be a better and 
mature person.  
I would also like to thank my committee members, Dr. Roberta King, Dr. Brett 
Lucht, Dr. Mindy Levine and Dr. Navindra Seeram for their time and support. I also 
thank University of Rhode Island, College of Pharmacy and the National Institutes of 
Health (NIH) for supporting me with teaching and research assistantships.  
I appreciate the past and present lab members, Drs. Vaidyanathan Ganesan, 
Sathyakam Patnaik, Sathyaraj Gopal, Vipin Jain for their constant support.  In particular, 
I would like to convey my special thanks to Vaidya who was always available to help and 
encourage me. Thanks to all my friends especially Mengyun, Yajuan, Yixin and Wenjing 
who cheered me up during my difficult and challenging periods.  
Finally, I have to thank my parents for supporting all my choices regardless right 
or wrong and thank their understanding of not being with them.  
 
 
 vii 
 
PREFACE 
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2014.  
MANUSCRIPT-III: A Systematic Spectroscopic and Thermodynamic Investigation 
of Slippage Mediated Frameshift Mutagenesis. 
This manuscript has been prepared for submission to ‘Journal of Molecular Biology’ for 
Publication. 
APPENDIX: Binding Kinetics of DNA-protein Interaction using Surface Plasmon 
Resonance. 
This appendix has been published in ‘Nature Protocol Exchange’ May 2013. 
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ABSTRACT 
We used surface plasmon resonance (SPR) to characterize the binding interactions 
between exonuclease-free Klenow fragment (Kf-exo
-
) and unmodified dG and dG 
adducts derived from arylamine carcinogens: fluorinated 2-aminofluorene (FAF), 2-
acetylaminofluorene (FAAF), and 4-aminobiphenyl (FABP). Tight polymerase binding 
was detected with unmodified dG and the correct dCTP.  The discrimination of correct 
versus incorrect nucleotides was pronounced with KD values in order of dCTP << dTTP < 
dATP < dGTP.  In contrast, minimal selectivity was observed for the modified templates 
with Kf-exo
-
 binding tighter to the FAAF-dG (koff: 0.02s
-1
) and FABP-dG (koff: 0.01s
-1
) 
lesions than to FAF-dG (koff: 0.04s
-1
).    
 
DNA is under constant assault by various endogenous and exogenous pathways, which 
result in different types of DNA damage. When a polymerase encounters a lesion, it can 
bypass by replicative polymerase, either inserting the correct base (error-free) or incorrect 
base (error-prone)
1
. The environmental arylamine carcinogens are known to form C8-
substituted dG adducts in vivo. We have shown that these lesions exist in a mixture of the 
base-displaced stacked, major groove B-type, and wedge conformers, with each leading 
to potentially unique sequence-dependent mutation and nucleotide excision repair 
outcomes
2
. 
It is important to understand the nature of interactions between polymerase and DNA 
lesions. Crystal structure and kinetic analyses have been used to  elucidate details of 
polymerase action at an atomic resolution
1
.  However, similar structural details of bulky 
DNA lesions have been challenging due to difficulties with obtaining crystals
3,4
. 
 3 
 
Consequently, various alternative techniques such as fluorescence, circular dichroism 
spectroscopy, gel mobility shift assays, and footprinting assays have been used
5,6
 
However, these techniques are either qualitative or semi-quantitative, non-compatible 
with fast dissociation rates, and require labeling of at least one of the components of 
interest. Although gel-based assay is relatively simple and robust, samples of interest will 
not be in chemical equilibrium and the system’s components are not amenable to testing 
across temperatures or salt concentrations
6
.  Surface plasmon resonance (SPR) is a chip-
based, label free solution technique that allows real-time monitoring of binding 
interactions between DNA and proteins
5-8
.   
In this report, a SPR study was conducted to examine polymerase interactions of DNA 
lesions derived from three fluorinated prototype arylamine carcinogens: 2-aminofluorene 
(FAF), 2-acetylaminofluorene (FAAF), and 4-aminobiphenyl (FABP) (Fig. 1c). We 
employed exonuclease-free E. coli DNA polymerase I Klenow fragment (Kf-exo
-
) as it 
avoids complication of proofreading activity. The features of fluorinated arylamines as 
effective conformational probes are well documented
2,9
. The present study takes 
advantage of the sensitivity of Biacore T200 to conduct SPR analysis of the binary and 
ternary polymerase complexes of bulky carcinogen-DNA adducts. 
Figure 1a and S1a show the construction scheme for a biotinylated hairpin-based 
template-primer strand on a gold sensor chip.  The hairpin-DNA was used to improve 
stability of oligonucleotides during performance of kinetics experiments. Arylamine-
modified 31-mer oligonucleotides were purified by HPLC and characterized by mass 
spectrometry (Fig. S2). The biotin-hairpin-template/primer strands were annealed, ligated, 
and purified by denaturing polyacrylamide gel (Fig. S1b). The incorporation of 
 4 
 
dideoxythymidine (ddT) was carried out using Kf-exo
-
 and the 3 terminal ddT allowed 
capture of the ternary polymerase/template-primer/ dNTP complex without primer 
extension.  
The kinetic assays were optimized with respect to regeneration buffer, surface density, 
and surface testing, as described elsewhere
10
 (Fig. S3). The binding kinetics analysis was 
performed by injecting varying amounts of Kf-exo
- 
to cover the hairpin template-primer 
DNA (Fig. 1b) coated on streptavidin surface in the absence (binary) and presence 
(ternary) of dNTPs (100 M). The injections were repeated three times for each 
concentration in random, and the resulting data were fitted to the Langmuir model (1:1) 
(Fig. 2). From the fitting, binding constants (kon, koff and KD) were calculated (Table 1 
and S1) using Biacore’s BIAsimulation software. The Chi-squared values for the 1:1 
fitting were less than 1% of Rmax (0.002–0.003 for all experiments with Rmax in the range 
of 0.7–3.5RU) (Figs. S4 and S5). The KD values for ternary systems were determined 
using affinity analysis as the association rate (kon) reaches the near-diffusion limit. This 
procedure allowed the monitoring of interactions between unmodified or adducted DNA 
with different polymerases on a single chip.  Furthermore, DNA over the chip surface 
was found to be stable for at least 7–10 days, without loss in binding activity under 
buffered reaction conditions.  
The results from the binding assay (Fig. S6) are summarized in Table 1. The Kf-exo
-
 
bound tightly to unmodified DNA in the presence of a correct incoming dCTP opposite 
the templating dG. However, relative to dCTP binding, binding tightness was reduced by 
30-, 60-, 34-, and 264-fold in binary, dATP, dTTP, and dGTP, respectively (Fig. 2b and 
Table 1). The discrimination ability of correct versus incorrect nucleotides was 
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significant, as the Watson-Crick base pair dCTP bound tightly and dGTP does not bind 
significantly. In contrast, the discrimination effect on Kf-exo
- 
binding was weaker for 
binding to FAF than for binding to unmodified DNA. The specificity of binding between 
the correct dCTP and incorrect nucleotides, as well as for the binary system, differed by 
only 2- to 16-fold. The tightness of Kf-exo
- 
binding in the presence of dCTP was reduced 
by 4-fold, as compared to that of the unmodified control. 
Moreover, the difference in binding affinity between dCTP and dATP was less for FAF-
dG (10-fold), as compared to that of unmodified DNA (60-fold) (Fig. 2b). The Kf-exo
- 
bound more tightly to FAAF (koff = 0.02s
-1
) and FABP-dG (koff = 0.01s
-1
) lesion sites than 
to the unmodified control (koff = 0.13s
-1
) while kon values are similar. However, 
discrimination between correct and incorrect nucleotides was not maintained with FAAF 
and FABP-dG, for which binding affinities differed by only 1- to 3-fold (Fig. 2b). 
Highly specific binding of Kf-exo
-
 to unmodified DNA in the presence of dCTP opposite 
a dG templating base is in line with the polymerase undergoing conformational change 
from an open to a closed system to form Watson-Crick base pairs
11
. However, Kf-exo
- 
does bind weakly with incorrect nucleotides, probably retaining the open polymerase 
conformation. In particular, the binding of dGTP is very poor compared to other 
nucleotides. 
To further confirm that the binding of polymerase to DNA is 1:1, theoretical Rmax values 
were calculated and compared with experimental values. The data presented here are 
consistent with data from sedimentation studies in which polymerase was shown to bind 
template-primer junction in a 1:1 ratio
12
. Interestingly, the KD value for Kf-exo
- 
binding to 
FAF adducts was higher in the presence of dCTP than with unmodified DNA (Table 1), 
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indicating that the lesion prevents the nucleotide-induced, catalytically-favored closed 
conformation. Previous studies have shown that the carcinogenic aminofluorene orients 
into the energetically favorable solvent-exposed major groove, which causes less 
disruption at the replication fork, but may perturb the groove structures and the geometry 
in the active site of the polymerase
3
.   
The aforementioned crystal structure of AF on T7 DNA polymerase showed fuzzy 
electron densities around the    carcinogenic aminofluorene moiety in line with sequence-
dependent conformational heterogeneity in solution
4
.  The present kinetics data also fit 
with previously published findings from a single nucleotide insertion assay study in 
which dATP was the next preferred nucleotide after dCTP
13
. 
The higher binding affinity of Kf-exo
- 
to the bulky N-acetylated FAAF lesion, compared 
to unmodified DNA, could be due to the adduct perturbing the template-primer junction 
while maintaining some specific interactions with amino acids on the active site of the 
polymerase. It has been shown that the AAF lesion has two hydrogen bond interactions 
between the N
2
-amino group of the modified guanine and Asp-534, as well as between 
the N7-guanine and Arg-566
4
. In addition, the lesion adopts a syn-glycosidic 
conformation wherein the fluorene moiety is inserted between the hydrophobic pocket of 
the O-helix finger subdomain. These changes also keep the polymerase in the open and 
maintain a distorted conformation of the subdomain fingers, causing the Tyr-530 residue 
to occupy the binding region of the nucleotide and preventing interaction between the 
incoming nucleotide and polymerase
4
. The present data are also in agreement with 
previous results from tryptic digestion studies, in which the polymerase was shown to 
bind very tightly to unmodified DNA in the presence of the correct nucleotide and to be 
 7 
 
insensitive to digestion; FAAF did not exhibit any additional stability in relation to the 
incoming nucleotide
14
. FAF adducts are known to exist in a sequence-dependent 
equilibrium of B and S conformers
2,9
. FABP is similarly  N-deacetylated; however, its 
biphenyl moiety is not as coplanar as fluorene, thereby resulting in a lesser base-
displaced stacked conformer population
15
.  Consequently, FABP may behave similar to 
FAAF at the replication fork in the active site of a polymerase.  
In summary, tight binding of Kf-exo
-
 was observed with unmodified dG in the presence 
of a correct dCTP in this study. Nucleotide selectivity was pronounced with KD values in 
the order of dCTP << dTTP < dATP < dGTP.  In contrast, minimal selectivity was 
observed for the modified templates: Kf-exo
-
 bound tightly to FAAF-dG and FABP-dG 
lesions as compared to FAF-dG. The SPR results for FAF and FAAF agreed with those 
obtained from gel-based assays,
16
 demonstrating SPR as a powerful and superior tool for 
studying protein/DNA interactions with bulky DNA lesions as it provides kon and koff 
rates.    
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Figure legends 
Figure 1: (a) Schematic representation of template-primer DNA constructs (b) 
oligonucleotide sequence used in the SPR assay and (c) the structures of arylamine-dG 
adducts 
Figure 2: (a) Sensorgrams of Kf-exo- binding with unmodified and arylamine-modified 
DNA adducts (fitted curves were overlaid as red lines) (b) Plot of specificity ratio of 
binary or wrong nucleotide to correct dCTP vs. unmodified DNA and modified adducts 
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Table legends 
Table 1: Dissociation constants (KD) for the unmodified dG and dG-arylamine adducts 
with Kf-exo
-
 using steady-state affinity analysis 
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Figure 1: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 13 
 
Figure 2:  
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Table 1:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Template Binary dCTP dATP dGTP dTTP 
-G- 1.5±0.5 0.05±0.1 3±2 13.2±12 1.7±0.5 
-G[FAF]- 0.4±0.3 0.2±0.1 1.98±1.7 3.2±1.4 1.8±1.8 
-G[FAAF]- 0.2±0.05 0.19±0.1 0.33±0.05 0.67±0.07 0.4±0.08 
-G[FABP]- 0.14±0.09 0.29±0.1 0.31±0.1 0.63±0.11 0.54±0.17 
‡
KD values are in nM 
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ABSTRACT 
Surface plasmon resonance (SPR) was used to measure polymerase binding interactions 
of the bulky mutagenic DNA lesions N-(2′-deoxyguanosin-8-yl)-4′-fluoro-4-
aminobiphenyl (FABP) or N-(2-deoxyguanosin-8-yl)-7-fluoro-2-acetylaminofluorene 
(FAAF) in the context of two unique 5’-flanking bases (CG*A and TG*A). The enzymes 
used were exo-nuclease-deficient Klenow fragment (Kf-exo
−
) or polymerase β (pol β).  
Specific binary and ternary DNA binding affinities of the enzymes were characterized at 
sub-nanomolar concentrations.  The SPR results showed that Kf-exo
−
 binds strongly to a 
double strand /single strand template/primer junction, whereas pol  binds preferentially 
to double-stranded DNA having a one-nucleotide gap. Both enzymes exhibited tight 
binding to native DNA, with high nucleotide selectivity, where the KD values for each 
base pair increased in the order dCTP << dTTP ~ dATP << dGTP.  In contrast to pol β, 
Kf-exo
–
 binds tightly to lesion-modified templates; however, both polymerases exhibited 
minimal nucleotide selectivity towards adducted DNA. Primer steady-state kinetics and 
19
F NMR results support the SPR data.  The relative insertion efficiency f
ins
 of dCTP 
opposite FABP was significantly higher in the TG*A sequence compared to CG*A.  
Although the Kf-exo
–
 was not sensitive to the presence of a DNA lesion, FAAF-induced 
conformational heterogeneity perturbed the active site of pol , weakening the enzyme’s 
ability to bind to FAAF adducts compared to FABP adducts. The present study 
demonstrates the effectiveness of SPR for elucidating how lesion-induced conformational 
heterogeneity affects the binding capability of polymerases, and ultimately the nucleotide 
insertion efficiency. 
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.INTRODUCTION 
 Polymerases are critical to the replication and repair of DNA.
1
 While replication of 
DNA is an essential first step for cell division, repair of DNA is needed when insults such 
as UV rays, environmental toxins, and some drugs chemically modify DNA.
2
 These 
modifications can yield a diverse array of mutations.
3
  To understand the mechanisms of 
DNA replication and repair, it is crucial to understand how a polymerase processes DNA 
lesions.
4, 5
   
 As part of ongoing carcinogenesis research, and to understand the mechanisms of 
DNA mutation and repair, we have been studying how the bulky and mutagenic 
arylamine-DNA lesions (Figure 1a) interact with a polymerase or a repair protein.
6-11
 
Using 
19
F NMR, microcalorimetric and other biophyisical methods, we have shown that 
the arylamine lesions adopt three unique conformations: base-displaced stacked (S), 
major groove B-type (B) and minor-groove wedge (W) depending on the location of the 
lesion (Figure 1b).
10-13
  The relative populations of S-, B-, and W- conformers depend on 
the nature of attachment on the central nitrogen (N-acetyl vs. N-deacetylated) and the 
hydrophobic carcinogen ring moiety (planar vs. twisted) as well as the base sequences 
(flanking vs. near long-range) surrounding the lesion.
13-15
   
 It has been shown that most replicative polymerases easily bypass the planar and N-
deacetylated aminofluorene (AF) adducts after a brief stall at the lesion site.  On the other 
hand, the bulkier N-(2-deoxyguanosin-8-yl)-2-acetylaminofluorene (AAF) analogs 
cannot be readily bypassed, and thus stall DNA synthesis.
16
  In vitro studies with X-
family polymerase β,  AAF adducts lead to -2 base deletion mutations, while AF extends 
full length primers.
17 
 A recent study via single-molecule fluorescence spectroscopy 
 18 
 
showed that high-fidelity polymerases cannot extend a primer whose terminus occurs 
across from AAF.18  In E. coli, AAF adducts results mostly in frameshift mutations, while 
both AF and AAF adducts cause point mutations .
19
 In mammals, both adducts afford 
point mutations. 
17
  This difference in mutagenic profiles has been attributed to the 
presence of a bulky acetyl group on the central nitrogen, which causes the AAF adduct to 
adopt a syn conformation. 
20
  In contrast, the AF adduct adopts an anti-/syn- conformation, 
while the N-(2′-deoxyguanosin-8-yl)-4′-fluoro-4-aminobiphenyl (FABP) adduct adopts 
exclusively an anti-conformation. 
9  Other factors influencing adduct-induced mutations 
include topology, insertion of the nucleotide opposite the lesion site, and the 
characteristics of the polymerase.21, 22 
 Numerous crystal structure and kinetic analysis studies are available and provide 
information on actions of native
23-25
 and damaged
2, 5, 26-34
 DNA with various polymerases. 
However, only few examples of replicative polymerases complexed with bulky arylamine 
modified-DNA are available with atomic resolution details,
 26, 27
 presumably due to 
difficulties with obtaining crystals. High-resolution solution NMR can offer dynamic 
information alternative to the static crystallography.
35,36
  However, some bulky DNA 
lesions cause conformational variation in the DNA and upon binding with a polymerase, 
which introduces additional challenges to the use of this method.
14,15,37-39
  As a result, 
most NMR studies thus far are limited to adducted DNA without full presence of 
polymerases and repair proteins.
40,41
  Theoretical/molecular dynamic simulations in 
conjunction with limited NMR and crystal data have been useful. 
4,40, 42, 43
   
 Other available techniques for biomolecular interactions such as electrophoretic 
mobility (gel shift or gel retardation assay), and filter-binding assays provide valuable 
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information on binding affinity.  However, these approaches either contribute little or no 
insight on the kinetic parameters underlying complex formation. Moreover, these 
techniques require strenuous work to determine binding parameters.
44 
  In addition, gel 
assays do not allow the samples of interest to be in chemical equilibrium due to fast 
dissociation rate during electrophoresis, and thus it is difficult to measure proper binding 
kinetics and thermodynamics.
44
  Finally, microcalorimetry such as isothermal titration 
calorimetry (ITC) is a fast and robust method that certainly could be used to characterize 
binding interactions and the thermodynamics of polymerase DNA interactions in free 
solution, but low affinity interactions would require higher protein concentrations.
44
 
 Surface plasmon resonance (SPR) is a powerful, chip-based, and label-free solution 
technology that can provide real-time information on kinetics and thermodynamics.
44-48
  
SPR relies on changes in the refractive index that are due to changes in mass, and can 
thus measure a small difference in binding (KD) at sub-nanomolar level. SPR is thus ideal 
for probing interactions of binary and ternary polymerase-DNA interaction.  We have 
recently communicated our initial SPR work on the binding affinities of Kf-exo
-
 to 
arylamine DNA lesions.
6,49
  Subsequently, a similar study was conducted to elucidate 
how FAF lesions affect the active site conformation of the human repair enzyme pol β, 
and how the structure and sequence of the DNA affects its ability to be repaired.
7
   
 In the present study, we are providing a complete set of SPR data on the binding of 
Kf-exo
-
 or pol β to FAAF and FABP lesions in two different sequences (CG*A and 
TG*A). To complement the SPR binding results, we also conducted dynamic 
19
F NMR 
as well as steady-state nucleotide insertion kinetics.  The results are discussed in terms of 
adduct-induced conformational heterogeneity, the effect of the 5-flanking base sequence, 
 20 
 
substrate specificity, and the nature of a polymerase. The purpose of the present paper is 
two-fold: 1) to give the full details of our previous SPR work (“Rapid Report”)6 and 2) to 
introduce SPR to the chemical toxicology community as a powerful alternative to 
existing techniques for investigating protein-DNA interactions.  As a result, the choice of 
polymerases used in the present study was based largely on the experimental systems in 
our previous work.
7,8, 50
  Obviously, future SPR studies should be expanded to a range of 
Y-family bypass polymerases, which is more likely to be involved in replication of bulky 
DNA lesions. 
MATERIALS AND METHODS 
 DNA sequences containing 5-biotin labeled 31-mer oligonucleotides, phosphorylated 
52-mer hairpin and 21-mer complementary sequences (Figure 2b, c) were purchased from 
Operon (Eurofin, Huntsville, AL) in desalted form and purified by reverse phase high-
performance liquid chromatography (RP-HPLC). All HPLC solvents were purchased 
from Fisher Inc. (Pittsburgh, PA) and used as received. The HPLC system was consisted 
of a Hitachi EZChrom Elite HPLC system with an L2450 diode array detector and a 
Clarity column (10 mm × 150 mm, 3 μm) (Phenomenex, Torrance, CA). The mobile 
phase system involved a 20 min linear gradient profile from 3 to 16% (v/v) acetonitrile 
with 100 mM ammonium acetate buffer (pH 6.5) at a flow rate of 2.0 mL/min. Kf-exo
–
 
(D424A) and pol  were received as gifts from Dr. Catherine Joyce (Yale University, 
New Haven, CT) and Dr. William Beard (NIEHS, Research Triangle Park, NC). 
 
19
F NMR  
 21 
 
 Approximately 70 µM of a FAAF- or FABP-dG modified 16-mer template was 
annealed with a 9-mer primer in a 1:1 molar ratio to produce ds/ss junction containing 
duplexes (Figure 3).  The samples were lyophilized and dissolved in 300 µL of typical 
pH 7.0 NMR buffer containing 10% D2O/90% H2O with 100 mM NaCl, 10 mM sodium 
phosphate, and 100 µM EDTA. All 
19
F NMR spectra were recorded using a dedicated 5 
mm 
19
F/
1
H dual probe on a Varian 500 MHz spectrometer operating at 476.5 MHz, using 
acquisition parameters described previously.
11,51,52
  The spectra were acquired in the 
1
H-
decoupled mode and referenced relative to that of CFCl3 by assigning external C6F6 in 
C6D6 at -164.9 ppm. 
19
F NMR spectra were measured at two different temperatures, 5 
and 25 C.   
 
Primer extension assay 
Standing start experiments  
 Single nucleotide/full length extension experiments for both FABP- and FAAF-dG 
adducts in Kf-exo
-
 were performed as described previously.
8
  Briefly, the 9-mer primer 
was 5-radiolabeled using [γ-32P] ATP and T4 polynucleotide kinase (T4 PNK) following 
the manufacturer’s protocol. The 32P-labeled primer (50 pmol) was annealed to either an 
unmodified or adducted template oligonucleotide (60 pmol) by heating to 95 °C for 5 min 
and then slowly cooling to room temperature in 3 h. For pol  assays, 1 nt-gap was 
generated by adding downstream 9-mer primer with 5-phosphate group while annealing 
with radiolabeled primer (9-mer) and template (19-mer).
7
  The ds/ss primer-template 
sequence (20 nM) was incubated with Kf-exo
−
 (0.5 or 1.0 nM) for 5 min to form a binary 
complex in Tris buffer (Tris, 50 mM pH 7.4; BSA, 50 g/mL; 5% (v/v) glycerol). The 
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reaction was initiated by adding a dNTP (100 µM)/MgCl2 (5 mM) solution to a binary 
mixture and incubated at 22°C for 10 min. The reaction was arrested with gel loading 
buffer (containing 50 mM EDTA (pH 8.0)/95% formamide solution). The quenched 
sample was heated to 95 °C for 5 min and immediately cooled on ice. The products were 
resolved with a denaturing polyacrylamide gel (20% polyacryamide (w/v)/7 M urea) 
electrophoresed at 2500 V for 4 h. The gel was exposed on a Kodak phosphor imaging 
screen overnight and scanned with a Typhoon 9410 variable mode imager.  
Steady-state kinetics analysis  
 To determine the efficiency of dCTP insertion opposite the adducted site, steady-state 
kinetic parameters for incorporation of the nucleotide opposite the unmodified and 
FABP-modified templates were determined by using the reported literature procedures.
7,8
  
The reactions were performed with pol  (0.5 nM) and oligonucleotide (20 nM)  at 22°C. 
For the unmodified sequence, reactions were performed in shorter time period of 0.5-10 
min for nucleotide incorporation and up to 30 min in the case of modified templates. The 
band intensities were quantitated using ImageQuantTL from GE Healthcare. The 
percentage of primer extended in kinetic assays was determined by taking the ratio of 
extended primer to the total amount of primer (unextended + extended primer). The 
kinetic parameters kcat and Km were determined as described earlier.
7, 8
 
SPR Measurements 
Arylamine-modified hairpin template/primer constructs  
 The modification of 5-biotin CGA/TGA sequences (31-mer) was carried out using the 
previously reported procedures (Figure 2)
6, 7
 and the modified products were purified by 
by RP-HPLC and characterized by MALDI-TOF mass spectrometer. Biotinylated 
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unmodified (20 M) or modified 31-mer (20 M) was annealed with 20 M of 52-mer 
hairpin by heating to 95C for 5 min and cooling down to room temperature (Figure 2). 
The annealed mixture was ligated by using 4000 U T4 DNA ligase in 1× ligase buffer for 
16 h at room temperature. The ligated 83-mer oligonucleotide was purified by 10% 
denaturing polyacrylamide gel (Figure S1) and extracted using crush and soak method. 
The extracted oligonucleotide was desalted using Illustra G-25 spin column. The desalted 
oligonucleotide was incubated with 2’, 3’-dideoxy-thymidine-5’-triphosphate (ddTTP) (1 
mM) in the presence of Kf-exo
-
 (1 M) and 5 mM MgCl2 for 12 h. The dideoxy-terminus 
DNA was purified by RP-HPLC (Figure S2) after precipitation of protein using phenol-
chloroform-isoamyl alcohol (25:24:1) followed by ethanol extraction.   
 
Characterization of oligonucleotides by MALDI-TOF 
 Either biotinylated 31-mer, 83-mer or 84-mer DNA sequences (100 pmol) was mixed 
with 2 L matrix containing 1 L of 3-hydroxy picolinic acid (3-HPA) (50 mg/mL 
dissolved in acetonitrile/water 50% v/v) and 1 L of diammonium hydrogen citrate 
(DAHC) (50 mg/mL dissolved in acetonitrile/water 50% v/v). MALDI-TOF experiments 
were performed using Axima Performance from Shimadzu Biotech. The mass 
spectrometric measurement of 31-mer oligonucleotides was carried out in a reflectron 
positive mode. The calibration of the instrument in reflectron positive mode was 
performed using low molecular weight oligonucleotide or peptide standard calibration kit. 
For high molecular weight oligonucleotides (>10,000 Da), calibration was done in a 
linear negative mode using 52-, 80-, 90-, 100-mer standards with laser power 120 in 
order to enhance the signal intensity. The spectral data was processed by using Shimadzu 
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Biotech MALDI-MS software with processing parameters as follows: smoothing filter 
width as 20 channels; baseline filter width as 80 channels and double threshold.  
 
DNA coating on biosensor chip 
 SPR measurements were conducted with Biacore T200 (GE Healthcare).  A 
carboxymethylated dextran coated CM5 chip supplied by GE Healthcare was used to 
immobilize streptavidin (SA) via the amine coupling kit on flow cells by following the 
previously reported literature.
6,7,49  
The EDC/NHS mixture was injected over the surface 
for 7 minutes followed by SA (50 g/mL dissolved in sodium acetate buffer, pH 4.5). 
The unreacted reactive esters were blocked with 1 M ethanolamine for 7 min. The 
running buffer used for immobilization was 1× HBS-EP
+ 
buffer containing 10 mM Hepes 
(pH 7.4), 150 mM NaCl, 3 mM EDTA and 0.05% non-ionic surfactant P20. The flow 
cells were immobilized with SA around 2,500 RU. After SA immobilization, the surface 
was washed with 50 mM NaOH for 60 s pulse and repeated for 5 times to remove the free 
SA until the change in response unit reaches below 20 RU. The surface was stabilized by 
injecting 3-4 times running buffer followed by equilibration with running buffer for 1 h. 
The 84-mer biotinylated DNA-hairpin sequences of either unmodified or adducted DNA 
(0.25-0.3 nM) were injected over the flow cells 2 or 4 for 60-120 s individually to 
achieve 0.7-3.5 RU. The flow cells were washed with running buffer to remove the 
unbound DNA and to stabilize the surface. Before conducting kinetics experiments, 1 
mM dideoxythymidine triphosphate (ddTTP) in the presence of Kf-exo
- 
(1 M) and 5 
mM MgCl2 was injected over the surface for 5 min followed by 0.05% SDS to remove 
the polymerase.  For pol  experiments, 1 nt-gap was created by using the same DNA 
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coating approach and in addition corresponding downstream complementary sequence 
(21-mer) containing 5-phosphate group (2 nM) was injected over the surface for 5 min.  
 
Real-time kinetic analysis 
 Kf-exo
-
 was injected with or without dNTPs (100 M) over the DNA surface in 
random order (neither ascending nor descending concentrations).  Each concentration 
was repeated twice. For binary system, varying concentrations of Kf-exo
-
 (0-10 nM) 
prepared in running buffer containing 1× HBS-P
+ 
along with 100 g/mL bovine serum 
albumin (BSA) and 5 mM MgCl2 was used. The polymerase was injected for 30 s with 
flow rate of 100 L/min followed by dissociation of polymerase. The surface was 
regenerated using 0.05% SDS with flow rate of 100 L/min and injection time was 30 s 
followed by extra wash with running buffer. After regeneration of the surface, the surface 
was stabilized with running buffer for 15 min. Initially three startup steps with running 
buffer and four times of zero concentration injection were performed to condition the 
surface. For ternary system, individual dNTP (100 M) was mixed with varying 
concentrations of Kf-exo
- 
and injected over the surface. The sensorgrams were double 
referenced and fitted using a 1:1 Langmuir model. The binding affinity constants (KD) for 
binary and ternary systems were calculated using steady-state affinity analysis in 
BIAevaluation software v1.0 as the association rate for the ternary system particularly 
with dCTP and unmodified dG reaches near diffusion limit. The sensorgrams for binary 
systems were globally fitted with BIAsimulation Basic kinetics module software by using 
experimental ka and kd values (Figure S7). 
     Similar experiments were carried out for pol  interaction studies with adduct present 
 26 
 
both at the non-gapped duplex DNA and 1 nt-gap DNA. Single nucleotide (1 nt)-gapped 
DNA was generated by annealing corresponding downstream primer. For non-gapped 
DNA, the concentration of pol  was varied up to 1000 nM while for 1 nt-gap was 0-100 
nM depending on dG adduct embedded. The binding constants were obtained using 1:1 
Langmuir model.  
 
RESULTS 
Model hairpin template/primer constructs  
 An overall scheme for the construction of the biotinylated hairpin-based template-
primer strands is depicted in Figure 2a. FABP- or FAAF-modified biotin-31-mer 
oligonucleotides were prepared according to published procedures.
7, 10, 12
   The 52-mer 
hairpin-DNA was annealed and ligated to the biotinylated 31-mer (Figure 2b, c).  ddTTP 
was incorporated at the 3 primer terminus using Kf-exo-.25, 53  The hairpin structure was 
created to improve the thermal stability of the oligonucleotide constructs on a gold chip 
during kinetics experiments.  As a result, the same oligonucleotide constructs could be 
used multiple times with different polymerases and buffer conditions.  Finally, the lesion 
was positioned at the 22
nd
 base, with 21 bases on the 5’-side and 28 bases on the 3’-side, 
in order to avoid close contact between the polymerase and the chip surface.  The 
resulting template/primer strands, containing the biotinylated 84-mer hairpin, were 
purified by denaturing polyacrylamide gel (Figure S1) and used for further study.  
      MALDI-TOF spectrum, obtained in reflectron mode, of the FAAF-modified biotin-
TG*A- 31-mer sequence is shown in Figure S3.  A distinctive peak at 9841.30 Da is in 
close agreement with theory (9839.90 Da, Δm/z: +1.40) and the inset is a linear negative 
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mode spectrum. The inset of b at 25925.76 Da corresponds to the 83-mer strand 
consisting of the biotin-31-mer -TG[FAAF]A- and the 52-mer hairpin in the absence of 
ddT at the primer terminus (theoretical 25923.00: Δm/z: +2.76). The inset of c at 
26206.70 Da corresponds to the 84-mer strand formed by adding ddT to the primer 
terminus of the 83-mer strand (26211.00 Da: Δm/z: -4.30).  The corresponding 
TG[FABP]A, CG[FAAF]A and CG[FABP]A sequences were similarly characterized 
(Figure S4-S6). All of the calculated and experimental m/z values are shown in Table S1.  
19
F NMR 
 To examine lesion-induced conformational heterogeneity, we measured 
19
F NMR 
spectra of modified 16/9-mer template/primer duplexes.  As shown in Figure 3, the 
19
F 
NMR spectra of FABP- and FAAF-modified duplexes in the CG*A and TG*A sequences 
are compared at 25 °C. FABP-duplexes exhibited a single peak at -116.4 ppm in both 
sequences, which is consistent with the chemical shift range observed previously for the 
anti-B-type FABP conformer.
9
  The bulky FAAF displayed three 
19
F signals with two 
prominent peaks of similar intensity at around -114 to -116 ppm, for both sequences. We 
have previously reported the chemical shift ranges that correspond to the  B-, S-, and W-
conformers of FAAF-modified duplexes, i.e., -115.0 to -115.5 ppm for the B-conformer, -
115.5 to -117.0 ppm for the S-conformer, and -117.0 to -118.0 ppm for the W-
conformer.
11,13
 Hence, the present FAAF-induced heterogeneity could be a variation of 
the B/S/W heterogeneity.  In contrast to the aforementioned study, however, the 
19
F 
signals in the present study are derived from the lesions at the ds/ss junction, not fully 
paired double helical duplexes.
8,12
  The relative shielding of 
19
F signals and the narrow 
the narrow chemical shift range (~ 2 ppm) in the present work are probably due to the 
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flexible lesions at the ds/ss junction. As a result, we could not unequivocally assign the 
signals to the B-, S-, or W-conformer.  
    
Primer extension assay 
  Single nucleotide incorporation was carried out using the E. coli exonuclease-deficient 
Klenow fragment (Kf-exo
-
) and the human base excision repair polymerase  (pol ) 
(Figure 4).  Like any other high-fidelity replicative polymerase, Kf-exo
- 
prefers the ds/ss 
replication fork as a template/primer DNA substrate.  In the unmodified DNA control, the 
primer was immediately elongated to full length in the presence of all four nucleotides 
and Kf-exo
-
 (data not shown). With the FABP-modified template, however, primer 
elongation was largely stalled at the lesion site, with some insertion of the correct dCTP 
opposite the lesion (Figure 4a). 
 Unlike Kf-exo
-
, pol  prefers a single nucleotide gap as a substrate.54, 55   With pol , 
there was no full extension of either the unmodified (not shown) or FABP-modified 
template (Figure 4b).  We observed preferential dCTP incorporation opposite the lesion.  
As for FAAF, no nucleotide insertion was observed with either Kf-exo
- 
or pol , even at 
high enzyme concentrations or longer incubation period (data not shown) because the 
lesion had completely blocked elongation.  
Steady-state kinetics 
 We conducted steady-state experiments to investigate the impact of conformational 
heterogeneity on nucleotide insertion kinetics.  The results for Kf-exo
-
 and pol  are 
summarized in Tables 1 and 2, respectively.  To examine the influence of lesions, we 
used the relative insertion efficiency f
ins
, which was defined as (k
cat
/K
m
)
modified or mismatched 
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/(k
cat
/K
m
)
unmodified
. With Kf-exo
-
, the f
ins
 of dCTP opposite -CG[FABP]A- was 500-fold 
lower than that of the unmodified control (Table 1).  This is contrasted with -
TG[FABP]A- which was reduced only 33-fold.  In the pol  assay (Table 2), the f
ins
 of 
dCTP opposite FABP in the CGA sequence was 142-fold lower than that of the control,  
while in the TGA sequence the fins was 59-fold lower than that of the control.  These 
results indicate that the nucleotide insertion efficiency is consistently greater in the TGA 
sequence compared to the CGA sequence, regardless of the polymerase structure.  We 
were unable to perform similar steady-state kinetics experiments for FAAF because this 
lesion caused a major blockage at the replication fork. 
 
SPR binding experiments 
DNA coating and mass transport limitation studies  After activation with 
streptavidin (SA), flow cells 1 and 3 were retained as blank references, and DNA was 
coated on the SA surface of flow cells 2 and 4. Surface testing, regeneration buffer 
scouting, and the mass transport limitation test were performed before the kinetics 
experiments as described previously.
6 
 DNA coating at 0.7 resonance units (RU) did not 
show any influence of mass transport; an increase in flow rate of the analyte did not alter 
the association rate. However, at 10 RU, mass transport became a limiting factor, as the 
association rate deviated with the flow rate of the analyte (data not shown). Based on this 
study of mass transport limitation, all the experiments were carried out in the DNA 
coating range between 0.7 and 3.5 RU.  
Kf-exo
-
  The sensorgrams for the binary binding between Kf-exo
-
 and the 
unmodified TGA controls or the modified TG*A oligonucleotide constructs are shown in 
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Figure 5a.  We performed steady-state affinity analysis of the binary and ternary 
complexes in the presence of four dNTPs (Figure 6).  A similar set of results for the CGA 
sequence have been reported previously
6 
and the results on the binding affinity of Kf-exo
-
 
to both TGA and CGA sequences are summarized in Table 3.   
 As for the unmodified controls, Kf-exo
-
 binds tightly in both sequences in the presence 
of the correct dCTP.  The affinity of binding for the CGA sequence was reduced by 30-, 
62-, 264-, and 34-fold in binary, dATP, dGTP and dTTP, respectively, compared to the 
correct dCTP binding (Table 3). Similar results were obtained for TGA, where the 
binding affinity was reduced by 15-, 39-, 180-, and 40-fold in binary, dATP, dGTP and 
dTTP, respectively (Table 3). These results are consistent with those of the nucleotide 
insertion assay, which showed preferential insertion of the correct dCTP. 
 Kf-exo
-
 bound strongly to the modified TG*A templates. In the TG*A sequence, the 
KD value for FABP was 4.9- fold greater than the control, and the KD value for FAAF 
was 8.8-fold greater than the control.  Similar changes were observed in the CG*A 
sequence, where the KD for FABP was 10.8-fold larger than for the control, and the KD 
for FAAF was 7.2-fold larger than for the control.  These differences are primarily due to 
the much slower dissociation rates observed for the modified template/primer for both the 
CG*A sequence (FAAF, kd: 0.02 s
-1
; FABP kd: 0.01 s
-1
) and the TG*A sequence (FAAF, 
kd: 0.01 s
-1
, FABP, kd: 0.01 s
-1
). The net stabilization energies were positive and ranged 
from 1.10 to1.47 kcal/mol (Table S2).  
Nucleotide selectivity was low in the modified ternary complexes. KD for the correct 
nucleotide was 0.19 – 0.25 nM with FAAF and 0.29 – 0.30 nM with FABP, while for the 
incorrect nucleotide, KD was 0.28 – 0.67 nM with FAAF and 0.31 – 0.66 nM with FABP.   
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Pol      For pol , binding assays were performed on two distinct substrates: non-
gapped ds/ds and 1 nt-gap.  The results for the binary and ternary systems on both CGA 
and TGA sequences are summarized in Table 4. Weak binding was observed for the non-
gapped DNA, with KD values of ~0.8 M (data not shown). In contrast, the binding 
affinity of pol  increased 1,000 fold with the 1 nt-gap.  
 As for the unmodified controls, pol  binds to the correct dCTP more tightly. The 
binding affinity for the dCTP is 2.7-fold higher in the TGA sequence, and 4.5-fold higher 
in the CGA sequence (Table 4).  In contrast to Kf-exo
-
, the binding in the binary complex 
between the modified template and pol β is less tight than that in the complex containing 
the unmodified template, where the differences in binding are approximately 3-fold for 
FABP and 5- to 6-fold for FAAF, respectively.  Similar to Kf-exo
-
, the binary complex 
with FAAF showed slower off rates (kd: 0.01 s
-1
) with pol  in both sequences.  The 
curve fits for dG-FAAF (Figure 5b) are relatively poor: however, the residual plots for 
the dG-FAAF/plo β binary complex (Figure S10) indicate a good curve fit within 1% chi2 
values of Rmax.  The complexes with B-conformeric FABP exhibited unusually faster 
dissociation rates for both the CG*A and TG*A sequences, where the kd values were 0.76 
s
-1
 and 0.40 s
-1
, respectively, and the  negative net stabilization energy was -1.04 and -
0.27 kcal/mol, respectively (Table S2). 
 Figure S9 show the sensorgrams for the ternary complexes between pol  and the 
FAAF- and FABP-modified CG*A constructs.  We have recently reported a similar set of 
binding results for the N-deacetylated FAF.
7 
 With the correct nucleotide dCTP, the pol  
binds 2.7- fold more tightly in the ternary complex than in the binary complex and 
~3,000-fold more tightly than to the non-gapped DNA. The binding affinity to the 
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incorrect nucleotide was 4 to 5-fold lower than to the correct dCTP. The lesion in the 1 
nt-gap reduced the binding affinity of pol   by 6-fold for FAAF and 3-fold for FABP, 
virtually eliminating the nucleotide selectivity of pol  at the lesion site.  The affinity for 
pol  binding decreased in the order dG > FABP > FAAF.   
DISCUSSION 
 In the present study, we have employed SPR to investigate the binary and ternary 
binding interactions of Kf-exo
-
 and pol β to two prototype arylamine-DNA lesions 
(FABP and FAAF) in the context of two different sequences (CG*A and TG*A).  Kf-
exo
-
 is a 68-kDa high fidelity replicative A-family bacterial DNA polymerase,
56
  which 
carries a polymerase and 3’-5’-exonuclease activities and has been used extensively as a 
model enzyme for studying adduct-induced DNA synthesis. Pol β is the smallest (39 kDa) 
eukaryotic polymerase, belonging to the X-family of base-excision repair DNA 
polymerases, and has been characterized extensively.
57
  With pol β, primer extension past 
AAF adduct was blocked, but full length products were shown to contain exclusively -2 
deletion mutations.
17
  Although its role is limited in base excision repair, pol β has been 
additionally implicated in the replication of various DNA damage.  For example, 
deregulation of pol β may enhance the genetic instability induced by bulky lesions such 
as cis-platin
32
 and UV radiation.
33
  Pol β can also bypass abasic site58 and bulky 
polyaromatic hydrocarbons adducts.
34
  FABP and FAAF are C8-substituted dG adducts 
adducts which contain structurally unique arylamine structures, i.e., N-
acetylated/coplanar-fluorene and N-deacetylated/twisted-biphenyl, respectively (Figure 
1a).  Finally, the two sequences (CG*A vs. TG*A) were selected because of their marked 
difference in the S/B population ratios observed with the N-deacetylated FAF.
11
   The 
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SPR results, along with data from 
19
F NMR and steady-states primer kinetics, elucidate 
how lesion-induced conformational heterogeneity alters the binding capacity of a 
polymerase and thus its nucleotide insertion efficiency.    
 
Model hairpin oligonucleotide constructs for SPR binding assays 
 We constructed the 84-mer hairpin-based oligonucleotides for SPR (Figure 2) based 
on the following considerations.  First, the incorporation of ddT at the 3-end of the 
primer prevents the usual nucleophilic attack of the 3’-hydroxyl to the incoming dNTP, 
and thus blocks the formation of a phosphodiester bond.
25,59
  This ensures the stability of 
the ternary complex polymerase/template-primer/dNTP for SPR measurements.  Previous 
assays using gel electrophoresis, single-molecule FRET, or crystallography have 
consistently shown that the absence of 3-OH at the primer terminus does not affect the 
affinity with which polymerases bind to binary and ternary complexes of DNA.
25,59
  
Second, while Kf-exo
-
 requires a minimum of 11 bases, because it covers approximately 
5 bases downstream from the primer/template junction and 6-7 bases upstream to the 3- 
primer terminus,
60
  pol β can operate on any length of DNA containing a 1 nt-gap.   
Binary and ternary binding affinities with unmodified control DNA 
  We observed very tight binding of Kf-exo
– 
with native unmodified dG, in the presence 
of the correct incoming nucleotide dCTP.  This system exhibited high nucleotide 
selectivity, with KD values increasing in the order dCTP << dTTP ~ dATP << dGTP 
(Table 3).  The SPR results are in agreement with nucleotide insertion assays, which 
showed exclusive insertion of the correct dCTP over other dNTPs.  Crystal structures 
usually indicate 1:1 DNA polymerase-DNA complexes.  2:1 and higher order complexes 
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have also been observed in solution by various biochemical and biophysical methods.
60
  
The stoichiometry, however, is highly concentration dependent.  As shown in Figure S11, 
comparison between theoretical and experimental Rmax for pol β and Kf-exo– are in good 
match, indicating a 1:1 complex. 
 Initially, we carried out a SPR binding assay of pol  using the non-gapped ds/ss 
junction replication fork.  The binding was very weak, with KD values in the range 
7
  However, upon introduction of the 1 nt-gap (Figure 2c), 
the DNA binding affinity of pol   increased 200- to 1,000-fold.  These results indicate 
that the presence of 5-PO4 enhances the binding affinity of 8-kDa lyase domain as well 
as the 31-kDa catalytic domain.  The observed differences in binding affinity are 
consistent with previous reports in which the lyase domain in the duplex (non-gapped) 
DNA was flexible.  Introduction of the 1 nt-gap enhances the binding affinity of the 
polymerase to DNA.
61
  The results are also in agreement with gel assays, which had 
previously shown that addition of the correct dCTP opposite unmodified DNA enhances 
the binding affinity of polymerase compared to other nucleotides, by an induced-fit 
model adopted by pol .61 
Lesion and sequence effects on binary binding affinities with modified DNA 
 An unusually greater binding of Kf-exo
-
 was observed for modified dG, where the KD 
of this interaction was 5 – 11-fold higher than the KD for interaction with the unmodified 
native DNA substrate.  The binary binding affinity decreased in the order FABP > FAAF > 
dG for the CG*A sequence, and FAAF> FABP > dG for the TG*A sequence (Table 3). 
Previous studies have also shown tighter binary binding of Kf-exo
-
 with the AAF 
adduct.
62
  Using gel-retardation assays, Dzantiev and Romano
62
 showed that the bulky 
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and hydrophobic AAF interacts with nearby hydrophobic amino acid residues, 
strengthening its binding to the active site of Kf-exo
-
.  The authors suggested that such 
lesion-induced conformational adjustment may block the conformational change required 
to properly accommodate an incoming nucleotide.
27
   
 It is well established that the N-deacetylated fluorinated analog FAF adducts (Figure 1) 
adopt sequence-dependent equilibrium between B- and S-conformers.  FABP is similarly 
N-deacetylated, but lacks a methylene bridge, resulting in a bulky twisted biphenyl 
moiety.
21
  In other words, FABP may behave like FAAF at the replication fork of the 
template in the active site of a polymerase. In contrast to the unmodified control, 
modified adducts displayed a significant decrease (7- to 13-fold) in dissociation rate, with 
positive net stabilization energy (Table S2).  The markedly slower off-rates are consistent 
with single-molecule FRET studies as well as gel shift assay in which the presence of the 
bulky DNA adduct stabilizes the binary complex and does not induce dissociation before 
the nucleotide incorporation.
16,61
 
 In contrast to Kf-exo
-
, pol β exhibited significantly lesser binary binding affinity to the 
modified templates.  Furthermore, the modified sequences exhibited significantly faster 
dissociation rates and more negative net stabilization energies. As in the ds/ss situation 
discussed above, it is likely that FAAF promote conformational heterogeneity in a 
sequence containing a 1-nt gap. Such heterogeneity may hinder the interaction of that 
sequence with key amino acids in the polymerase, thus preventing the polymerase from 
undergoing conformational change that is necessary for strong binding. 
Lesion and sequence effects on ternary binding affinities with modified DNA    
 Nucleotide selectivity was low in the ternary complexes with Kf-exo
-
, where the KD 
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values indicate poor discrimination between the correct (KD 0.19 – 0.30 nM) and 
incorrect (KD 0.28 – 0.67 nM) nucleotides. Variance in these values ranged from 1.5- to 
3.5- fold (Table 3).  This poor selectivity does not depend on the nature of the lesion 
(FABP vs. FAAF) or the 5-flanking base (CG*A vs. TG*A).  The lack of nucleotide 
selectivity appears to be in agreement with the results of tryptic digestion studies, in 
which the AAF-polymerase complex maintains an unstable non-catalytic open 
conformation in the presence of any dNTP.
63  
 In other words, AAF-modification did not 
stabilize the complexes in relation to the incoming nucleotide.  This is contrasted with 
native DNA, to which the polymerase binds very tightly in the presence of the correct 
nucleotide dCTP, and is insensitive to digestion.  Our 
19
F NMR results (Figure 3) indicate 
a complex conformational heterogeneity of the bulky FAAF at the ds/ss templating 
position, which may prevent the polymerase from properly accommodating an incoming 
dNTP.  This reasoning is in accord with the weak electron densities observed for the 
arylamine base in the active site of T7 DNA polymerase,
27  where the authors of the 
previous study also concluded that conformational heterogeneity may hinder the insertion 
of an incoming nucleotide.  
 The low selectivity for incoming nucleotides could also arise from the high stability of 
binary complex, which may hinder the polymerase’s ability to recognize the incoming 
nucleotide.  No crystal structures or high-resolution NMR structures are currently 
available for complexes between any DNA polymerase and ABP or the fluorinated FABP.  
In the present study, FABP in both sequences exhibited a single 
19
F signal possibly for a 
B- or a B/S-conformational mix owing to the presumed conformational flexibility at the 
ds/ss junction.  These NMR data, albeit in the absence of a polymerase, are in agreement 
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with the gel based kinetics data, which reveal a preference towards inserting the correct 
nucleotide over other nucleotides (Table 1).  
 In the case of Kf-exo
-
, TG*A sequence favored the insertion of dCTP more efficiently 
than the CG*A sequence.  The relative insertion efficiency f
ins
 of dCTP opposite FABP 
was significantly lower in the CG*A (500-fold) and TG*A (33-fold) sequences compared 
to the unmodified controls (Table 1).  This 15-fold difference in fins is puzzling because 
FABP at ds/ss junction exhibited a single 
19
F signal in both sequences (Figure 3). 
However, we have shown previously that FAF in the duplex setting displayed a greater S-
conformer in the CG*A duplex (50%) relative to the TG*A (38%).  As mentioned above, 
it is likely that the absence of co-planarity in FABP would embrace intermediate 
structures between FAAF and FAF, as observed from 
19
F NMR, gel and SPR assays.   
 The SPR results with pol β (Table 4) indicated that a modified templating base 
weakens the polymerase binding affinity and the nucleotide selectivity (Figure S9, Table 
4). The reduced binding affinity of pol β to the modified template DNA could be related 
to the lesion-induced conformational heterogeneity in the active site of the polymerase.  
In the closed conformation, key amino acids such as Lys 234 and Tyr 271 interact with 
the minor groove of the primer strand, while Arg 283 interacts with the template strand of 
DNA.  As mentioned above, it is possible that the FAAF at the 1 nt-gap may hinder the 
active site geometry, and thus prevent the conformational change necessary to form the 
catalytic ternary complex. We previously observed similar conformational heterogeneity 
caused by FAF bound to 1 nt-gap DNA in both the absence and presence of pol β.7  The 
results are also consistent with translesion synthesis studies in which the minor groove 
conformation benzo[a]pyrene diol epoxide- N
2
-dG adducts creates steric clash with the 
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active site of pol  , thereby reducing the insertion rate.64  These results are in agreement 
with the steady-state kinetics data that show significant reductions in the f
ins
 of dCTP 
opposite FABP in the CG*A and TG*A sequences (142- and 59-fold, respectively), 
relative to the corresponding unmodified controls.   
 The question is how to reconcile the apparent lack of discrimination between dNTP at 
the binding step (Figure 7; Tables 3 and 4) with the clear preference for accurate insertion 
of dCTP (Figure 4; Tables 1 and 2).  We have recently shown that the AF adduct can 
change its binding characteristics at the replication fork or in a single nucleotide gap in 
the active sites of DNA polymerases.
7
  Similarly, it is plausible that the dynamics of 
FABP and FAAF-induced conformational heterogeniety could be altered to 
accommodate an incoming dNTP within the active site of polymerases in a way that 
favors the incorporation of the correct base dCTP.   
.   
SPR as a powerful tool for probing polymerase action 
In the present study we have taken advantage of the sensitivity of SPR, which allowed 
us to probe the delicate interaction between polymerases and DNA strands containing 
arylamine-DNA lesions at the binary and ternary complex levels.  We were able to 
measure a sub-nanomolar difference in binding affinity among dNTPs.  We found that 
0.7 – 3.5 RU of DNA coating was sufficient, with no significant interference from mass 
transport limitation.   
The binding specificity ratios (KD of the control binary complex over the KD of a 
ternary complex) in the presence of dNTPs, for the unmodified (dG) and FAAF- and 
FABP-modified lesions are plotted as in Figure 7. The dNTPs are color-coded in the plot. 
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We observed highly specific binding between Kf-exo
-
 and the native DNA substrates in 
the presence of the correct dCTP (green) opposite a dG templating base (Figure 7a,b).  
This is consistent with the polymerase undergoing conformational change, from open to 
closed, to form Watson-Crick base pairs.   Kf-exo
-
 binds weakly with the incorrect 
dNTPs, probably retaining the catalytically incompetent open conformation. The binding 
of dGTP (pink) with Kf-exo
-
 was particularly poor.  Similar binding results were obtained 
with pol β (Figure 7c,d) although the affinities for modified ternary complexes were 
generally weaker than those with Kf-exo
-
.  In both enzymes, however, we observed no 
discernible nucleotide specificity (dNTPs) and sequence effects (CG*A vs T*GA).  
KD values for the ternary complexes for unmodified DNA were determined using 
affinity analysis because the association rate (ka) reaches the near-diffusion limit in native 
DNA. This procedure allowed for the monitoring of interactions between unmodified or 
adducted DNA, with different polymerases on a single chip.  The present work also 
demonstrates the utility of SPR in distinguishing the substrate preference of different 
polymerases (e.g., ds/ss vs.1-nt gap for pol β).  To our knowledge, this is the first 
comprehensive use of SPR to probe nucleotide insertion kinetics during the action of a 
polymerase. Furthermore, the present SPR work advances the limits of SPR 
technology,
48,65
  demonstrating that SPR can measure sub-nanomolar affinity differences 
between incoming nucleotides and the active site of a polymerase.  
 In conclusion, we have characterized the SPR binding affinity of the mutagenic FABP 
and FAAF lesions bound to Kf-exo
−
 and pol β.  Kf-exo− binds strongly to ds/ss 
template/primer DNA, whereas pol  prefers gapped DNA.  Tighter binding was 
observed between unmodified dG and Kf-exo
–
 or pol  . The systems exhibited 
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nucleotide selectivity, with KD values increasing in the order of dCTP << dTTP ~ dATP 
<< dGTP.  Unlike pol , Kf-exo– binds tightly to both FAAF and FABP lesions in the 
binary systems. With lesion-modified templates, both polymerases exhibited minimal 
nucleotide selectivity.  The relative insertion efficiency f
ins
 of dCTP opposite FABP was 
significantly higher in the TG*A compared to the CG*A sequence and the unmodified 
controls.  While the lesion effect was not significant in Kf-exo
–
, the active site of pol  is 
sensitive to the FAAF-induced conformational heterogeneity.  Our SPR data are 
complemented by primer steady-state kinetics and 
19
F NMR data, and provide valuable 
insights into how lesion-induced conformational heterogeneity in DNA alters the action 
of polymerases, and thus affects the nucleotide insertion efficiency and coding potential. 
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FIGURE LEGENDS 
Figure 1. (a) Chemical structures of FAAF- and FABP-dG adducts (b) Major (upper 
image) and minor (lower image) groove views of the prototype B-, S-, and W- conformers 
of arylamine dG-lesions in CPK model with the DNA duplex in grey surface (color code: 
arylamine lesion, red; modified-dG, cyan; dC opposite the lesion site, green). Note that 
the arylamine lesion (red) in W-conformation is wedged in the narrow minor groove.  
Figure 2. (a) Schematic representation of template–primer DNA constructs for SPR 
assays; Hairpin template-primer oligonucleotide constructs for (b) Kf-exo
-
 and (c) pol .   
Figure 3. 
19
F NMR spectra of FABP and FAAF adducts in the CGA and TGA duplexes 
at ds/ss junction at 25 °C.   
Figure 4. Assays of full-length and single-nucleotide incorporation into FABP-adducted 
CG*A and TG*A sequences with (a) Kf-exo
-
  and (b) pol . 
Figure 5. Sensorgrams of binary complexes of (a) Kf-exo
-
 and (b) pol  with  unmodified 
and modified TGA sequences (1:1 binding fitted curves are overlaid as red lines).  
Figure 6. Steady-state affinity analysis of interaction of Kf-exo
-
 with (a) -TG[FAAF]A- 
and (b) -TG[FABP]A- sequences.  
Figure 7.  Plots of nucleotide specificity ratio (KD-binary/KD) with (a, b) Kf-exo
-
 and (c, 
d) pol β for unmodified and modified TG*A and CG*A DNA templates.  The dNTPs are 
color-coded in the plots. KD-binary-dG represents KD of unmodified DNA-polymerase 
binary complex and denominator KD represents the ternary complex of unmodified DNA 
(or) binary and ternary complexes of adducted DNA. 
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TABLE LEGENDS 
Table 1. Steady-state kinetics parameters for insertion of dCTP opposite unmodified and 
FABP-dG adduct with Kf-exo- 
Table 2. Steady-state kinetics parameters for insertion of dCTP opposite 
unmodified and FABP-dG adduct 1 nt gap with pol     
Table 3. SPR binding affinities (KD)* of unmodified TGA/CGA and arylamine dG-
adducts with Kf-exo
- 
(steady-state affinity analysis) in the binary and ternary systems 
Table 4. SPR binding affinities (KD)* of unmodified TGA/CGA and arylamine dG-
adducts with pol  (1:1 binding) in the binary and ternary systems 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Table 1 
 
Sequence 
Context  
Incoming 
dNTP  
kcat  
(min
-1
)  
Km, dCTP  
(M)  
kcat/Km  
(µM
-1
 min
-1
)  
fins 
-CGA-  dCTP  21.9(1.4)  0.80 (0.24)  27.3(8.4)  1.00 
-CG[FABP]A-  dCTP  0.44(0.05)  6.62(3.37)  0.06(0.03)  0.002 
-TGA-  dCTP  3.10 (0.31)  0.23 (0.14)  13.8 (8.3)  1.00 
-TG[FABP]A-  dCTP  0.32(0.02)  0.66 (0.30)  0.48(0.22)  0.03 
fins = (kcat/Km) modified/(kcat/Km)unmodified dG control  
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Table 2 
    fins = (kcat/Km) modified/(kcat/Km)unmodified dG control  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sequence Context  
Incoming 
dNTP  
kcat  
(min
-1
)  
Km, dCTP  
 (M)  
kcat/Km  
(µM
-1
 min
-1
)  
fins  
-CGA-  dCTP  1.14(0.08)  1.98(0.73)  0.58(0.21)  1.00  
-CG[FABP]A-  dCTP  0.60(0.09)  135(41)  0.004(0.001)  0.007 
-TGA-  dCTP  0.83(0.06)  4.75(1.48)  0.17(0.05)  1.00  
-TG[FABP]A-  dCTP  1.02(0.14)  298(69)  0.003(0.001)  0.017 
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Table 3  
 
Sequence  Binary  dCTP  dATP  dGTP  dTTP  
-TGA-  1.3(0.3) 0.09(0.08) 3.5(1.1) 16(8) 3.60(0.95) 
-CGA-
a
  1.5 (0.5)
 
 0.05(0.02)  3.1(2.2)  13(12)  1.70(0.53) 
-TG[FAAF]A-  0.15(0.05) 0.25(0.06) 0.42(0.18) 0.38(0.10) 0.28(0.19) 
-CG[FAAF]A-
a
  0.21(0.05)  0.19(0.11) 0.33(0.05)  0.67(0.07)  0.43(0.08) 
-TG[FABP]A-  0.27(0.02) 0.30(0.03) 0.44(0.01) 0.66(0.08) 0.36(0.07) 
-CG[FABP]A-
a
  0.14(0.10) 0.29(0.12) 0.31(0.13) 0.63(0.11)  0.54(0.17) 
 
a 
KD values were taken from ref. 6
 
 
*KD values are in nanomolar (nM). 
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Table 4 
 
Sequence  Binary  dCTP  dATP  dGTP  dTTP  
-TGA-  0.80(0.17) 0.30(0.09) 1.6(0.3) 1.40(0.15) 1.2(0.2) 
-CGA-  0.90(0.10)
 
 0.20(0.12)  2.10(0.09)  2.10(0.09)  1.8(0.2) 
-TG[FAAF]A-  4.50(0.15) 3.10(0.16) 2.70(0.09) 4.60 (0.12) 1.50(0.04) 
-CG[FAAF]A-  5.20(0.12)  4.40(0.08) 3.7(0.1) 1.90 (0.05)  1.10(0.21) 
-TG[FABP]A-  2.60(0.25) 2.20(0.23) 2.10(0.17) 2.20(0.16) 1.80(0.12) 
-CG[FABP]A-  2.80(0.21) 1.80(0.08) 2.00 (0.08) 2.10(0.07) 1.80(0.06) 
 
For non-gapped duplex DNA (ds-DNA) with pol , KD values exceeds 0.8 M.  
*KD values are in nanomolar (nM). 
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Abstract 
 
We have conducted a series of systematic studies to probe the conformational 
mechanisms of arylamine-induced -2 base deletion mutations frequently observed in the 
E. coli NarI mutational hot sequence (5’---CGGCG*CN---3’; N= dC and dT) during 
translesion synthesis (TLS). We employed two well-characterized fluorinated bulky DNA 
lesions [N-(2’-deoxyguanosin-8-yl)-2-fluoro-2-aminofluorene] (FAAF) and [N-(2’-
deoxyguanosin-8-yl)-4’-fluoro-4-aminobiphenyl] (FABP) derived from the 
environmental carcinogens 2-aminofluorene and 4-aminbiphenyl. Our work focused 
primarily on elucidating the effects of lesion size, bulkiness and overall topology and the 
3’-next flanking base N in producing an -2 slipped mutagenic intermediate (SMI), the 
bulge structure responsible for arylamine-induced -2 frameshift mutagenesis.  To that end, 
we examined two chemical simulated TLS models, in which the FAAF/FABP lesion was 
positioned at G3 position of two 16-mer NarI sequences (5’-
CTCTCG1G2CG3
*
CNATCAC-3’, N=C: NarI-dC Series; N=T: NarI-dT Series). These 
templates were each annealed systematically with increasing primer lengths in the full 
length and -2 deletion pathways and their thermodynamic, conformational, and binding 
profiles at each elongation step were measured by various biophysical techniques 
including spectroscopic (dynamic 
19
F NMR/CD), thermodynamic (UV-melting/DSC) and 
affinity binding (SPR).  The results showed that the Streisinger-based -2 bulge formation 
is initially triggered by the conformational stability of the G3*: C base pair at the ds/ss 
replication fork as well as the nature of base sequences surrounding the lesion site.  The 
extent of conformational instability of the G3*: C pair determines the nature of a slippage 
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(‘CG’ vs. ‘C’) and subsequent primer elongation yields the respective -2 G3*C or CG3* 
bulge structures for FAAF and FABP, respectively. Each bulge structure exists in a 
mixture of B-SMI and S-SMI, in which the bulky lesion is located outside the bulge 
(‘solvent exposed’) and inserted into the bulge (‘solvent protected’) respectively, and 
their conformational rigidity increases as a function of primer lengths. We found that the 
B-/S-SMI population ratios are dependent on various structural characteristics primarily 
the bulkiness (‘N-acetyl), coplanarity, and overall topology as well as the 3’-base 
sequence (N) next to the bulge formation.  The results indicate the importance of 
conformational stability, heterogeneity and flexibility in the mechanisms of bulky 
arylamine-induced frameshift mutagenesis.   
 
Introduction  
Arylamine is an important group of ‘bulky’ environmental pollutants that has 
been implicated in various sporadic human cancers such as the bladder, breast, and liver 
cancer.[1] 2-Aminofluorene and its derivatives have been most extensively studied as 
model bulky carcinogens. In vivo, these chemicals are reduced to N-hydroxylamine and 
subsequently activated to the acetyl or sulfate derivatives by the action of ubiquitous N-
acetyltransferase or sulfotransferase enzymes.[2] Consequently, these pro-carcinogenic 
esters produce highly reactive electrophilic nitrenium ions, which are known to interact 
directly with cellular DNA to form DNA adducts.[2]  In vivo, 2-aminoflurene produces 
two major C8-subsituted dG adducts, N-(2’-deoxyguanosin-8-yl)-2-aminofluorene (dG-
C8-AF, simply designated as AF here on), and N-acetyl-(2’-deoxyguanosin-8-yl)-2-
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aminofluorene (dG-C8-AAF, simply designated as AAF here on).[3] The related 
arylamine 4-aminobiphenyl is a known human bladder carcinogen that also binds to dG 
at C8 to form N-(2’-deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP, designated as 
ABP here on) as a major adduct.  The structures of AF and AAF differ only in that the 
latter contains a bulky acetyl group on the central linking nitrogen (Figure 1).  Despite the 
structural similarity, they produce different mutational and repair outcomes. In E. coli, 
AF produces both point and frameshift mutations, whereas AAF results in mostly 
frameshift mutations.[4-7] However, both lesions produce primarily G to T point 
mutations in the COS-7 mammalian cells replication.[8, 9] The N-deacetylated AF adduct 
in fully paired duplexes adopts an equilibrium between syn-glycosidic stacked (S) and 
anti-glycosidic major groove (B)-type conformations.[4-6, 10] In contrast, the N-
acetylated AAF adduct adopts a mixture of the base-displaced stacked (S)-, the major 
groove binding B-type (B), and the minor groove binding wedge (W) conformations.[4-7]  
Both AF and AAF induce S/B/W-conformational heterogeneity and their population 
ratios depend on the nature of the base sequence neighboring the lesion-modified dG, 
thus having a direct impact on their mutational and repair outcomes. As an example, S-
conformation destabilizes DNA duplexes and causes DNA bending, allowing a greater 
nucleotide excision repair.[11]  The S/B conformeric AF is processed by high fidelity 
polymerases albeit with low frequency, after a short stall at the lesion site. On the 
contrary, the S/W-conformeric and distorting AAF lesion is a strong blocker of 
replicative polymerase, consequently requiring the recruitment of special bypass 
polymerase for translesion synthesis (TLS).[12] The S/B-conformational heterogeneity 
has also been observed in recent crystal studies of several mutagenic arylamines 
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complexed with replicative and bypass polymerases.[10, 13-16] Very little is known 
about the structure and conformation of the ABP adduct. However, accumulated evidence 
indicates that ABP exists mostly in B-type conformation in fully-paired complementary 
DNA duplexes.[17] This is rationalized by the fact that ABP is not as coplanar as AF 
because of the missing methylene carbon at C9. 
 Arylamine carcinogens produce two general types of mutation, the base and 
frameshift mutations.  The latter usually involves a shift of one to two or multiple bases, 
causing the loss of genetic information. The molecular mechanisms of frameshift 
mutation have been studied in certain mutagenic sequences.  The G: C rich NarI 
sequence (5-G1G2CG3CNA-3) in E. coli is one such example and has been considered as 
a unique mutational hotspot especially for AF- and AAF-induced frameshifts mutations. 
The bulky lesion AAF at G3 position induces frameshifts at greater frequency and their 
propensity is modulated by the nature of the nucleotide in the N position (C ~ A > G >> 
T).[18-20] As an example, -2 deletion mutations arise primarily due to the extrusion of 
AAF-G3 with neighboring cytosine bases into two bases misalignment through the 
formation of a -2 base slippage mutagenic intermediate (SMI), resulting into dinucleotide 
GC deletion.  In contrast, adduction at G1 and G2 does not induce -2 deletion mutations 
because of the lacking repetitive GC dinucleotide. Similarly in the monotonous runs of G 
the extrusion of AAF-G3 into ‘-1 base SMI’ during replication produces -1 deletion 
mutations. This process for frameshift mutagenesis is known as “Streisinger Slippage 
Model”, which is proposed by Streisinger and colleagues decades ago.[21, 22] Compared 
to AF, the bulkier N-acetylated AAF has shown much greater propensity to induce 
frameshift mutation in the NarI sequence.  AAF is a strong blocker in highly replicative 
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polymerase, and is bypassed by the low fidelity polymerase, ultimately producing various 
deletion mutations.[6, 7, 23, 24]   
Clearly, the nature of polymerases can also contribute to the efficiency of deletion 
mutations.  Gill and Romano have shown that the AAF in the NarI sequence specifically 
interferes with the active site of E. coli DNA polymerase I Klenow fragment to induce 
deletion of the GC dinucleotides past AAF.  In addition, they showed a very different 
SMI structure on non-NarI sequence in the active site of the polymerase.[25]  Fuchs 
group showed that DNA synthesis past G3-AAF lesion in the NarI sequence in the 
presence of pol II also leads a GC dinucleotide deletion, whereas pol V is responsible for 
its error-free bypass in E. coli.[19] The crystal structures of AAF-modified template-
primer replication fork bound to the tight active site of T7 DNA polymerase showed that 
the hydrophobic AAF lies behind the O-helix and stuck in a hydrophobic pocket of finger 
subdomain, thus allowing the polymerase to adopt an open conformation.  Such 
conformational anomaly results in strong blockage, triggering a slippage leading to 
various frameshift mutations during TLS.[7] Bulky lesions have also produced multiple 
conformations in the spacious active sites of various bypass polymerases, which may 
account for the different replication efficiencies including frameshift mutations.[24]   
Using primer extension assays coupled with MALDI-TOF mass spectrometry, 
Schorr and Carell have shown that frameshift mutation is triggered by the unstable 
molecular association of the AAF-dG lesion with the correct incoming nucleotide dC.[26]  
Such configurations have been observed in both replicative and bypass polymerases and 
are likely to promote the lesion-containing dG and flanking bases to slip to form bulge 
structures. Hence, the stability of bulged-out structures and subsequent elongation will 
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determine the propensity for frameshift mutagenesis. To that end, we recently performed 
systematic structure and conformational studies of FAAF-modified NarI-sequence based 
−1, −2, and −3 deletion duplexes.[27] FAAF is the 19F analog of AAF. These SMIs 
existed in a mixture of the so-called external “solvent exposed” B-type (B-SMI) and 
inserted “solvent protected” “stacked” S (S-SMI) conformers, with the population of the 
S conformer and thermodynamic stability in the order of −1 > −2 > −3 deletion duplexes. 
The results showed greater thermal and thermodynamic stabilities of S-SMI over the 
flexible B-SMI, which supports the aforementioned Carell’s hypothesis. We also studied 
NarI-based -2 deletion [(5’-CTCGGCG*CNATC-3’) (5’-GATNGCCGAG-3’), N = dC 
or dT] duplexes, in which G* was FAF, the 
19
F analog of AF. These sequences mimic a 
SMI for -2 deletion mutations.  The results indicated that the NarI-dC/-2 deletion duplex 
adopts mostly a S-SMI conformer, whereas the NarI-dT/-2 deletion duplex exists as a 
mixture of S-SMI and various ‘exposed” B-SMI (Figure 1).[28] 
In the present study, we hypothesize that the NarI-induced frameshift mutagenesis 
is stimulated by the conformational stability of SMI formed during TLS.  The 
conformational, thermodynamics, and binding affinity details of the two progressive TLS 
models were examined, in which the FAAF/FABP lesion is positioned at G3 position of 
16-mer NarI sequence (5’-CTCTCG1G2CG3
*
CNATCAC-3’, N=C: NarI-dC Series; N=T: 
NarI-dT Series). These templates were both annealed systematically with increasing 
primer lengths (full length extended or -2 deletion), and their thermodynamic, 
conformational, and binding profiles at each elongation step were investigated and 
analyzed.  We have utilized a powerful array of biophysical techniques such as 
differential scanning calorimetry (DSC), surface plasmon resonance (SPR), as well as 
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circular dichroism (CD) and dynamic 
19
F and imino NMR spectroscopy.   The results are 
discussed the critical role of conformational stability, heterogeneity and flexibility in the 
mechanisms of bulky arylamine-induced frameshift mutagenesis.   
 
Materials and Methods 
Caution: Aminofluorene and aminobipheyl are animal, human carcinogens respectively 
therefore caution is required when handling. 
All crude oligodeoxynucleotides (oligo, 2-10 µmol scale) in desalted form were 
obtained from Eurofins MWG operon (Huntsville, Al, USA) and purified by using 
reverse phase high performance liquid chromatography (RP-HPLC). The HPLC system 
consisted of a Hitachi EZChrom Elite HPLC unit with an L2450 diode array detector and 
a Phenomenex Clarity C18 column (150*10mm, 5.0 um). All HPLC solvents were 
purchased from Fisher Inc. (Pittsburgh, PA, USA). 
Preparation of FAAF modified DNA. The 16-mer NarI dC/dT series were used 
and their respective primers are listed in Figure 2. The G3 in the sequence 5’-
CTCTCG1G2CG*3CNATCAC-3’ (G*=FAAF; N = C or T) was site-specifically modified 
by FAAF adduct according to published procedures.[4, 29]  Briefly, 1 mg of N-acetoxy-
N-2-acetylamino-7-fluorofluorene was first dissolved in absolute ethanol and added to 3 
mL sodium citrate buffer (10mM, pH 6.0) containing approximately 200 μM of 
unmodified template (-CTCTCG1G2CG3CNATCAC-3’, N = C or T). The mixed solution 
was placed in a 37 °C water bath shaker for 5 min. 3 mL Ether was added into reaction 
mixture to extract the extra FAAF diester and water layer of the mixture was collected 
and filtered with 0.2 μm filter paper.  The worked out reaction mixture was injected to 
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reverse phase preparative HPLC (Figure 5a) and appropriate peaks were purified up to 99% 
purity. In theory there should be a total of seven FAAF adducts due to the presence of 
three guanines in the model sequence: three mono-, three di- and one tri-adduct.  As such, 
a stringent HPLC condition is required.  Our HPLC mobile systems entails a gradient of 
3-9% acetonitrile for 5min followed by 9-30% acetonitrile for 20-min, in pH 7.0 100 mM 
of ammonium acetate buffer with a flow rate of 2.0 mL/min.  
Preparation of FABP modified DNA. Similarly as FAAF modification, FABP was 
synthesized and was used to modify 16-mer NarI dC/dT sequence.[5, 17] Generally, 3 
mg of N-acetoxy-N-trifluoroacetyl-7-fluoro-4-aminobiphenyl was dissolved in absolute 
ethanol and mixed with approximately 200 μM of unmodified sequence in sodium citrate 
buffer at 37 °C water bath for 30 min. The reacted mixture was ether extracted and 
filtered then injected in RP-HPLC system and chromatogram was shown in Figure 7a. 
The modified DNA was collected and purified up to 99% purity by repeating the mixture 
injections following the method involving a gradient system of 7.5-12.2% acetonitrile in 
100 mM of ammonium acetate buffer with a flow rate of 2.0 mL/min for 30min, followed 
by 12.2-40% for 5min and then 40%-7.5% for 5min.   
All seven modified adducts were isolated and three mono-adducts were 
characterized by MALDI-TOF using 3’→5’ or 5’→3’ exonuclease enzyme digestion 
method. The isolated G3-FAAF/FABP modified 16-mer sequences were each annealed 
with appropriate primers with different length to form the various ds/ss duplexes starting 
from n-1, n, n+1, n+2, n+3, n+6 to full duplex (Figure 2) for structural studies. A similar 
set of unmodified templates with appropriate primers was also prepared as controls. 
G3 adduct characterization. The FAAF/FABP modified mono-adducts were 
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characterized by enzyme digestion using matrix assisted laser desorption ionization-time 
of flight (MALDI-TOF).  The MALDI matrix solution was prepared by mixing 1:1 of 3-
hydroxypicolinic acid (3-HPA, 50 mg/mL) and ammonium citrate dibasic (50 mg/mL). 
The DNA samples (200 pmol) were mixed with 1 μl snake venom phosphodiesterase 
(SVP, 0.1 unit/μl) and 1 μl bovine spleen phosphodiesterase (BSP, 0.01 unit/μl) 
respectively for 3’- or 5’- enzyme digestion. Spot 1 μl digest solution with 1 μl matrix 
mixture on the plate every 30 seconds and air-dried. The MALDI-MS spectra were 
obtained in reflectron mode and analyzed using Shimadzu Axima performance.  
UV thermal melting experiments.  UV thermal melting experiments were carried 
out using a Cary100 Bio UV/Vis spectrophotometer equipped with a 6*6 multi-cell 
chamber and 1.0 cm path length. The cells temperatures were controlled by a built-in 
Peltier temperature controller. Various duplex solutions were prepared in solutions 
containing 0.2 M NaCl, 10 mM sodium phosphate and 0.2 mM EDTA (pH 7.0) with a 
concentration range of 1.2-6.4 μM. Thermal melting curves were monitored and 
conducted at 260 nm absorbance by varying the temperatures of the cell (1
o
C/min). Each 
melting experiment contained forward/reverse scans and was repeated five times. 
Thermodynamic parameters of bimolecular reactions were obtained and calculated using 
the program MELTWIN version 3.5.[30] 
Differential Scanning Calorimetry (DSC). All calorimetric samples were 
measured using Nano-DSC from TA Instrument (Lindon, UT, USA). 100 μM solutions 
containing unmodified or G3-FAAF modified template with various primers were 
prepared by dissolving in a pH 7.0 buffer containing 20 mM sodium phosphate and 0.1 M 
NaCl and degassed at least 10 min under vacuum. The TLS samples were scanned 
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against the blank buffer from 15 to 85 °C at a rate of 0.75 °C/min; at least five repetitions 
including forward/reverse were measured. Raw data were collected in the form of 
microwatts vs. temperature. A buffer vs. buffer scan was provided as a blank to be 
subtracted from the sample scan and normalized for heating rate. The area under the 
resulting curves was proportional to the transition enthalpy, ΔH. ΔG and ΔS can be 
calculated according to previous described procedures.[31] Due to the separation 
difficulty of G3-FABP mono-adduct, DSC experiment for FABP series was not 
conducted.   
Circular Dichroism (CD) spectra.  CD experiments were obtained on a Jasco J-
810 spectropolarimeter equipped with a Peltier temperature controller. G3-FAAF/FABP 
modified template (10 μM) as well as the unmodified control template were annealed 
with an equimolar amount of primer in 400 μl of a buffer which contains 0.2 M NaCl, 10 
mM sodium phosphate, 0.2 mM EDTA (pH 7.0) and placed in a 1.0 mm path-length cell. 
All the CD samples were incubated at 85 
o
C for 5 min and cooled to room temperature to 
ensure duplex formation. CD spectra were acquired from 200 nm to 400 nm at a scanning 
rate of 50 nm/min, along with every 0.2 nm with 2 s response time. The final data were 
the average of 10 accumulations scan with 25-point adaptive smoothing algorithms.  
Dynamic 
19
F-NMR experiments. Approximately 100 μM of G3-FAAF/FABP 
modified 16-mer template was annealed with an equimolar amount of various primers to 
produce appropriate template-primer samples and lyophilized. The samples were 
dissolved in 250 μl of NMR buffer (10% D2O/90% H2O, pH 7.0 containing 100 mM 
NaCl, 10 mM sodium phosphate and 100 μM EDTA) and filtered through a 0.2 μm 
membrane filter into a Shigemi NMR tube. All 
1
H and 
19
F NMR results were obtained 
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using Varian NMR spectrometer with a HFC probe operating at 500.0 and 476.5 MHz, 
respectively, following the previous reported acquisition parameters.[28][32] Each 
spectra was recorded with 1.0 s recycle delay. Imino proton spectra was recorded at 5 °C 
to 60 °C using a phase sensitive jump return sequence and referenced to DSS. 
19
F NMR 
spectra was acquired in the 5-70 °C temperature range with increment of 5 or 10 °C in the 
1
H-decoupled mode and referenced to C6F6 in C6D6 at -164.9 ppm. A total of 1200 scans 
were acquired for each dynamic 
19
F NMR. The line shape simulations were analyzed 
using WINDNMR-Pro version 7.1.6 according to the reported procedures.[10]  
Surface Plasmon Resonance (SPR).  Biacore T200 instrument from GE 
Healthcare was employed to measure the strength of duplex binding affinity during 
model TLS experiments in polymerase free solutions. In order to coat DNA on the 
streptavidin immobilized chip surface, 5’ biotin labeled 16-mer NarI sequence (5’-biotin-
CTCTCGGCGCNATCAC-3’, N = C or T) was designed and purchased from Eurofins 
MWG operon in desalted form.  The NarI sequence was used exactly the same as 
thermodynamic/conformational studies except the 5’ biotin attachment. Around 10 μM of 
5’-biotylated NarI 16-mer dC/dT was modified with FAAF and FABP following the 
routine reaction procedure and purified by RP-HPLC and later characterized by MALDI-
TOF using 3’ enzyme digestion. The HPLC elution method for biotin labeled DNA 
modification was different from non-biotin labeled reaction because of the increasement 
of hydrophobicity biotin attachment. The FAAF-dC G3 modified template was purified 
using RP-HPLC with a gradient method system of 5-15% acetonitrile with 100 mM of 
ammonium acetate buffer at a flow rate of 2.0 ml/min for 10 min followed by 15-38% 
acetonitrile for 5 min and 38%-5% for 5min, while FAAF-dT G3 mono-adduct was 
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purified starting from 8%-15% acetonitrile for 20 min then followed by 15-38% 
acetonitrile for 10min and 38-8% for 5min in ammonium acetate buffer with 2ml/min 
flow rate. The elution method for FABP modification was also different where starting 
from 7.5% to 13% for 40 min, followed by 13-38% for 25 min and 38-7.5% for 5 min at 
2 ml/min flow rate. The mono-adducts were characterized by MALDI-TOF using 3’ 
enzyme digestion, since 5’ of DNA was labeled by biotin, the 5’ exonuclease enzyme did 
not apply in this case.  
Carboxymethylated CM 5 chip was activated by amine coupling kit according to 
published procedures.[33] Generally, EDC/NHS mixture was injected over the chip for 7 
minutes and followed by coating streptavidin (SA, 50 ug/ml dissolved in sodium acetate 
buffer, pH 4.5) on flow cell 2 and 4, while flow cell 1 and 3 were left as blank. 1M 
ethanolamine was injected over the surface to block the unreacted esters. Five pluses of 
50 mM NaOH was injected over the chip to remove the unbound SA and running buffer 
stabilized the surface for 20-30 min before DNA coating. Flow cell 2 and 4 were coated 
around 200 RU unmodified DNA and FAAF/FABP modified G3 dC/dT, respectively 
under the manual control mode. Different lengths of complementary sequences were 
prepared in HBS-P
+
 buffer (10 mM Hepes, 150 mM NaCl, 0.05% surfactant P20 at pH 
7.4) and injected over the chip surface at 25 °C with 100 s contact time and 360 s 
dissociate time at 15 μl/min flow rate. 50 mM NaOH was used as regeneration solution 
and injected over the chip for 30 s to remove the complementary sequences. Dissociation 
rate constants (kd) were determined and analyzed using Scrubber software, version 2.0 
(Myszka and collaborators, BioLogic Software) in Kd-alone fitting mode.   
Results 
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Translesion synthesis (TLS) model Systems: 
Two TLS models were designed, in which FAAF or FABP lesion is at G3 position 
of a 16-mer NarI sequence (5’-CTCTCG1G2CG3
*
CNATCAC-3’, N = C: NarI-dC Series; 
N = T: NarI-dT Series).  FAAF and FABP are fluorine-tagged AAF and ABP lesions, 
which are intended for obtaining dynamic 
19
F NMR spectra.  The underline 12-mer 
portion of this 16-mer NarI sequence is identical to that used in our previous study, in 
which the sequence effect of the FAF was investigated in the context of -2 deletion 
mutation.[28]  In that study, the NarI-dC/-2 deletion duplex was found to adopt the S-
SMI conformer exclusively, whereas the NarI-dT/-2 deletion duplex showed multiple 
conformers, presumably consisting of S- and B-SMI conformers among others. Initially, 
we tried to use the same TLS sequences; however, the initial 12/5-mer template/primer 
(e.g., n-1) was too short to form proper duplexes to give meaningful thermo-melting and 
thermodynamic parameters. As such, two more bases were included on both sides (CT on 
the 5’ and AC on the 3’) to make a 16-mer, whereas the inner core was kept exactly the 
same.  
A total of four -2 deletion SMI TLS models were produced for each FAAF and 
FABP lesion (Figure 2) in the dC and dT series and the corresponding unmodified 
controls. Four unmodified control TLS models were also prepared, such as fully paired 
complementary and -2 deletion duplexes.  Figure 2A shows the fully extended duplex 
control models formed by annealing the FAAF/FABP-16-mer templates with appropriate 
primers, i.e., specifically n-1(16/7-mer), n (16/8-mer), n+1(16/9-mer), n+2(16/10-mer), 
n+3(16/11-mer), and n+8(16/16-mer).  As for the SMI models, the 16-mer templates 
were similarly annealed primers to produce appropriate -2 SMI, specifically, n-1(16/7- 
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mer), n (16/8-mer), n+1 (16/9-mer), n+2 (16/10-mer), n+3 (16/11-mer), and n+6 (16/14-
mer).    
Sequence Issues:  
Figure 3b shows two different -2 SMI models assumed for each lesion, i.e., G3*C 
and CG3* bulges for FAAF and FABP respectively, based on the previous high resolution 
1
H NMR and fluorescence results that are described below.  Using the simple Streisinger 
model depicted in Figure 3a, insertion of the correct cytosine opposite the lesion at G3* is 
the first step.[34]  The potentially unstable G3*: C pair causes a polymerase to pause at 
the replication fork, triggering a slippage of the nascent strand and leaves two bases bulge 
out in the template. However, there are two slippage possibilities, either a G3*C or a 
CG3* bulge out.  As detailed in Figure 4, the G3*C bulge out involves a slippage of two 
terminal bases (“CG” slip) in the primer hydrogen bonded with the downstream 
complementary 5’-G2C-3’ dinucleotide.  Alternatively, CG3* bulge out can be formed by 
a single base “C” slippage. Regardless, continued replication of either scenario will lead 
to a chemically identical daughter strand that is two bases shorter than the parent strand. 
Figure 4 shows that each of the two pathways (two bases “CG” or one base “C” slippage) 
is expected to produce a conformational mixture of S-SMI and B-SMI. Both the G3*C or 
CG3* bulge out scenarios will lead to the same -2 deletion mutation.  The biological 
outcome of the two models is identical, however, it is important to understand the 
structural and sequence aspects of the SMI involved in the different lesions.  Evidence 
indicates the importance of the thermodynamic stabilities of the initial base pairing of 
G3*: C at the replication fork. The delicate conformational structures of bulged-out SMI 
may determine the propensity for frameshift mutagenesis. 
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There are conflicting reports as to which SMI structure is responsible for the 
NarI-based -2 deletion.  Mao et al [35] conducted NMR/molecular modeling studies on a 
12/10-mer -2 deletion duplex [(5’-CTCG1G2CG3*CCATC-3’) (5’-GATGGCCGAG-3’)], 
in which G3 is modified with AF. Their NMR results showed the exclusive presence of 
the CG3* bulge out S-SMI (underlined above), in which the AF-modified guanine in the 
syn conformation and 5’-C reside in the major groove and the aminofluorene moiety is 
fully inserted into the bulge.  This result is consistent with the results from our 
19
F NMR 
and thermodynamic investigation in the same sequence context, which showed a 
conformational rigid S-SMI structure. On the contrary, NMR studies by Milhe et al on a 
AAF-modified on a similar 12/10-mer NarI duplex (5’-ACCG1G2CG3*CCACA-3’) (5’-
TGTGGCCGGT-3’)] revealed about ~80% of the G3*C bulge out SMI structure 
(underlined above), in which the AAF moiety is inserted into the duplex.[36] Unlike the 
AF case above, however, this S-SMI structure was not defined into a three-dimensional 
model because of conformational heterogeneity.  Furthermore, the conformational nature 
of the remaining 20% sample was not clearly defined.  Nevertheless, these results taken 
together indicate two very different lesion dependent slippage pathways, i.e., CG3* and 
G3*C bulge structures for AF and AAF, respectively.   
The structures of AF and AAF are essentially identical except that AAF possesses 
a bulky N-acetyl group on the central nitrogen of adduct, thereby exhibiting unique 
conformational features and different mutational and repair outcomes. The term “N-
acetyl factor” was previously coined to describe their repair differences. Schorr and 
Carell [26] showed that AAF-induced -2 frameshift mutation on NarI sequence by the 
bypass polymerase pol  indeed follow the Milhe’s [36] G3*C bulge out model (Figure 
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3b). We have utilized fluorescence spectroscopy (unpublished) to investigate the two 
SMI pathways by using sequences, which include the fluorescent tag pyrrolo-
deoxycytidine (
P
C) in either 5’- or 3’-side of the lesion. The fluorescence results 
indicated that AAF and AF induce G3*C and CG3* slipped mutagenic structures, 
respectively, supporting the NMR results discussed above. Therefore, the conformational 
stability and flexibility of the G3*: C base pairing at the replication fork dictates the types 
of a slippage, i.e., the conformationally flexible N-deacetylated AF promotes one base (C) 
slip, whereas the bulky and rigid N-acetylated AAF induces two base (CG) slippage.  
Evidently, the nature of the adduct structure (N-acetyl, bulkiness, coplanarity, overall 
topology) and base sequence contexts surrounding the lesion are important factors for 
determining the types of -2 frameshifts. FABP is considered as an analog of FAF because 
both are N-deacetylated, thus susceptible for conformational heterogeneity; however, 
FABP lacks a bridging methylene group, therefore less coplanar than the FAF.  Hence, 
the G3*C bulge model was selected for FAAF and the CG3* bulge model for FABP. 
Preparation and characterization of modified template sequences  
The 16-mer NarI template sequence (5’-CTCTCG1G2CG3CNATCAC-3’, N = C 
or T for dC and dT series, respectively) was treated with either an activated FAAF or 
FABP, according to the biomimetic procedures published previously.[4, 28, 29]  In 
principle, there should be at least seven adducts because of the three guanines in the NarI 
sequence; such as three mono-, three di- and one tri-adduct. The guanines in the sequence 
maintain similar chemical reactivity, and consequently it is possible to regulate the 
relative ratios of mono-, di- and tri- adducts by adjusting reaction time.  The complexity 
of the adduct profiles called for development of an efficient HPLC separation method.  
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Previously, the separation of this complex mixture took 90 min to collect all seven 
modified peaks (Figure 6b).[11] In the present study, an efficient HPLC method was 
developed to purify the same reaction mixture in a much shorter time frame (Figure 6a) 
(see Material and Methods for details).  Figure 6 compares the two HPLC chromatograms.  
Figure 6a shows the separation of all seven modified sequences in near base-line 
resolution in less than 20 minutes. The un-reacted 16-mer oligo appeared at 5.5 min, 
while the FAAF-modified sequences are in the range of 11–14 min (mono-FAAF 1, 2, 3), 
16–19 min (di-FAAF 4, 5, 6), and 20 min (tri-FAAF), respectively. This result is in clear 
contrast to the old HPLC profile wherein the mono-adducts (peaks 1–3) appeared in 28–
35 min, di adducts (peaks 4–6) in 45–56 min, and the tri adduct peak 7 at around 85 min 
(Figure 6b). The initial adduct mono-, di- and tri-FAAF assignments were based on the 
UV intensity of the absorption shoulders in the range of 300–320 nm, the intensity of 
which is known to be proportional to the aminofluorene chromophores, 1:2:3 for mono-, 
di- and tri-adducts, respectively (Figure 5b).  The structural identities of the FAAF-
adducts were characterized by exonuclease enzyme digestions-MALDI-TOF mass 
spectrometry as described below. The results showed that peak 1was G1, peak 2 was G3, 
and peak 3 was G2 in both the NarI dC and dT sequences (Figures 8–13).  
Similarly, the treatment of the same 16-mer NarI dC/dT sequence with FABP (5’-
CTCTCG1G2CG3CNATCAC-3’, N = C or T for dC and dT series) gave a reaction 
mixture that showed all three group of adducts in less than 45 min, such as the three 
mono-adducts at 19–24 min, three di-adducts at 35–38 min and the tri-adduct at 42 min 
(Figure 7a). The UV shoulder absorbance in the range of 300-320 nm indicated the 
number of FABP adducts (mono di, and tri). The three mono-FABP adducts were 
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collected with repeated HPLC injections and were characterized by MALDI-TOF as 
detailed below. The results indicated that peak 1was G1, peak 2 was G3, and peak 3 was 
G2 in both the NarI dC and dT sequences (Figures 14–19). The order of elution was same 
as the FAAF case above. 
NarI-FAAF-16-mer dC sequence:   
The FAAF modified NarI 16-mer dC sequence (5’-
CTCTCG1G2CG3*CCATCAC-3’) was characterized previously using ESI-QTOF-
MS.[11] The overall HPLC elution patterns were similar.  All three mono-FAAF adducts 
have been characterized by the analysis of MALDI-TOF spectra (Figures 8-10). Here 
details of the characterization of peak 2 as G3 modification is presented, which is relevant 
to the present study.   
Figure 9 shows the MALDI-TOF spectra of 3’-5’ SVP (a) and 5’-3’ BSP (b) 
exonuclease digestions of peak 2 at different time points (0–120 s for SVP and 0–30 min 
for BSP). These two enzymes are known to remove one base at a time from the 3’ and 5’ 
side, respectively. The peak at 5017 m/z at 0 s was the mass of the modified template as a 
control (i.e., before digestion). However, at 30 s of digestion, the control 16-mer 5017 
m/z was replaced, with the appearance of three lower molecular weights 3508, 3218, and 
2929 m/z. These fragments correspond to the 11-, 10, and 9-mer fragments with two, one, 
and no extra base on the 3’-flanking side of the FAAF-lesion site (see inset), respectively.  
However, these signals disappeared quickly, leaving the 9-mer 2929 m/z (theoretical 
2928.67 m/z; 5’-CTCTCG1G2CG3[FAAF]-3’) as the only one remaining peak at 120 s.  
The results indicated peak 2 as FAAF-G3 modified. The 5’-3’ exonuclease digestion 
(Figure 9b) was carried out similarly, which confirmed the 3’-5’ exonuclease digestion 
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above.  The parent 16-mer control signal m/z 5017 at 0 s was replaced with the exclusive 
signal at m/z 2883, which corresponds to the fragment, cleaved one base before the lesion 
(see inset).  An additional peak was observed at m/z 2594 after 30 min of digestion which 
corresponds to the 8-mer containing FAAF at G3. The 5’-3’ exonuclease action was much 
slower than the 3’-5’-exonuclease counterpart. Therefore, these results confirmed peak 2 
as the G3-FAAF-modified 16-mer dC series, which are consistent with the ESI-MS 
results published previously.[11] The HPLC peaks 1 and 3 were similarly characterized 
and their spectra are included in Figure 8 and 10. The results identified the HPLC peaks 1, 
2, and 3 as the FAAF at G1, G3, and G2, respectively.  
NarI-FAAF-16-mer dT sequence:  
The FAAF modified dT sequence has not been characterized previously. Three 
mono-adduct peaks were characterized by MALDI using both 3’ and 5’ enzyme 
digestions. Figure 11 shows the 3’ (a) and 5’ (b) enzyme digestions of peak 1, where 
5031 m/z peak at 0 s corresponds to the control peak of 16-mer FAAF modified dT 
sequence, whereas at 90 s and 120 s, peaks at 4742 and 4428 m/z showed the gradual 
digestion fragments, respectively. Peaks of 2310 and 1980 m/z at 150 s correspond to the 
7- and 6-mer fragments with one and no extra base on the 3’ side of FAAF lesion (see 
inset), respectively. These data indicate the FAAF-modification at G1 (5’-
CTCTCG1[FAAF]-3’; see inset).  The 5’-3’ digestion shown in Figure 11b indicated 
3844 m/z at 60 min which corresponds to one extra base at 5’ side of the lesion. The 
results confirmed peak 1 as FAAF-modification at G1.  
Figure 12 shows the MALDI spectra of peak 2 with 3’-5’ (a) and 5’-3’ (b) 
digestions. The 5031 m/z peak at 0 s corresponds to the control peak before digestion, 
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whereas the 3218 and 2928 m/z peaks at 120 s –180 s correspond to 10- and 9-mer 
fragments, with one and no extra base at the 3’-side of the lesion site, respectively. The 
results indicate a FAAF-modification at G3 position (CTCTG1G2CG3[FAAF]-3’). The 5’-
3 digestion at 60 m showed 2896 m/z, which corresponds a signal to one base extra at the 
5’-side of the lesion G3(CG3[FAAF]CTATCAC-3’). These digestion results confirmed 
that peak 2 was G3.  
As for peak 3 (Figure 13), the 5031 m/z in both digestions corresponds to the 
molecular ion.  In 3’-5’ digestion, the 2599 and 2310 m/z peaks at 150 s correspond to 9- 
and 8-mer fragments containing modified G2. On the contrary, the 5’-3’ digestion profiles 
at 30-60 m revealed signals at 3844 and 3555 m/z, corresponding to 11- and 10-mer with 
one or no base extra to the 5’ side of the lesion, respectively. These data confirmed that 
peak 3 was G2.  Hence, the results identified the HPLC peaks 1, 2, and 3 as the FAAF at 
G1, G3, and G2, respectively.  
NarI-FABP-16-mer dC sequence:   
FABP modification produced three mono adduct peaks (peak 1, 2, and 3) as 
expected. Figure 14, 15, and 16 show the MALDI-TOF spectra of both 5’-3’ and 3’-5’-
exonuclease digestion mixtures derived from the peak 1, 2, and 3, respectively.  Figure 14 
shows the parent ion 4963 m/z at 0 s before digestion.  Upon digestion, fragments at 1929 
and 3487 m/z were persisted after 3’-5’ and 5’-3’ exonuclease digestion, respectively.  
These fragments correspond to bond cleavages right at the lesion site of G1. As for peak 2 
(Figure 15), persistent fragments were observed at 2876 and 2540 m/z after 3’-5’ and 5’-
3’ digestions, respectively. The results indicate FABP modification at G3.  Peak 3 (Figure 
16) produced persistent fragments at 2258 and 3159 m/z after 3’-5’ and 5’-3’ digestions, 
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respectively, which are consistent with the G2 modification. Hence, these results 
identified peaks 1, 2, and 3 as FABP modification at G1, G3, and G2. 
NarI-FABP-16-mer dT sequence:   
Figures 17–19 show the digestion results of NarI-FABP-16-mer dT sequences.  In 
all cases, the parent ions were observed at 4980 m/z before digestion.  Upon 3’-5 enzyme 
digestion, peak 1, 2, and 3 produced fragments at 1930, 2878, and 2259 m/z, respectively, 
which indicated FABP modification at G1, G3, and G2, respectively. Upon 5’ enzyme 
digestion, peak 1, 2, and 3 produced fragments persisting at 3504, 2844, and 3175 m/z, 
confirming the same assignments.  
The HPLC order of elution should be noted to be identical with FAAF/FABP 
modified NarI 16-mer sequences, i.e., peak 1, 2, and 3 were G1, G3, and G2, respectively, 
regardless of lesion and next flanking base sequences.  
 
UV melting:  All TLS model duplexes showed mostly monophasic sigmoidal curves on 
UV melting (Figures 20 and 21). A correlation (R2 > 0.9) between lnCt and Tm
-1
 was 
observed, confirming typical helix-coil melting transitions. Tables 1-4 summarize the 
thermal and thermodynamic parameters calculated from UV melting curves.  
UV melting Curves:   
FAAF series: Figure 20 shows UV-melting curves of FAAF-modified full (NarI-
FAAF-Full-dC and NarI-FAAF-Full-dT) and -2 deletion duplexes (NarI-FAAF-SMI-2-
dC and NarI-FAAF-SMI-2-dT) in the dC and dT series along with corresponding 
unmodified control models. The unmodified n-1 duplex (16/7-mer) in the dC series 
(Figure 20a, dotted black), in which the primer is elongated to the one base before the 
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lesion, was not clearly defined presumably because of a short primer. However, the 
duplex melting gradually improved to produce well-behaved sigmoidal curves, i.e., 
increase of Tm as function of temperature (n to n+8). In contrast with the FAAF modified 
model, the Tm from n to n+3 barely increased. The results indicated a lesion-induced 
destabilization. By contrast, the corresponding -2 SMI (FAAF-SMI-2-dC) duplex 
exhibited well-behaved melting curves of all duplexes including the n-1, with generally 
higher melting (for n to n+2).  However, for the unmodified -2 SMI model, the Tm did 
not change between n and n+3. A higher melting of -2 SMI over the full duplex at n and 
n+1 indicated lesion-induced duplex stabilization. The opposite result was observed in 
the dT series, in which the Tm -2 SMI at n and n+1 was lower than that of the full duplex. 
This finding indicated the direct effect of the next flanking base N (e.g., T over C) on the 
bulge stability of FAAF at G3 (Figure 20). 
FABP series: Figure 21 shows the UV-melting curves of FABP-modified full and 
-2 SMI duplexes in both dC and dT series along with the unmodified controls. As in 
FAAF, FABP stabilized the duplex at n-1 in both the dC and dT series. FABP modified -
2 SMI models showed a gradual increase of Tm, suggesting FABP-induced stabilization 
in the -2 bulge structure.  
UV melting thermodynamics: 
FAAF-dC series:  Figures 22a and 22b show plots of UV-based thermal-melting 
(Tm) and thermodynamics (ΔG) for the FAAF modified full (NarI-FAAF-Full-dC; left) 
and -2 SMI (NarI-FAAF-SMI-2-dC; right) duplexes of dC Series with increasing length 
of primers (n+8 and n+6 for full duplex and -2 SMI, respectively). FAAF-modified 
duplexes (red, empty circles) are compared with unmodified ones (blue, filled circles). In 
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the unmodified full duplex model, values increased consistently as expected from 
standard primer elongation (blue lines). However, for the unmodified -2 SMI models 
(blue lines), the thermal and thermodynamic values slightly changed from n to n+3. In 
both full and -2 SMI cases, the lesion effects were minimal at and prior to the lesion site 
(n-1 to n+1), but became significant between n+2 and full (n+6 and n+8 for -2 SMI and 
Full, respectively).  In the -2 SMI models, the modified (NarI-FAAF-SMI-2-dC) showed 
greater stability (higher Tm and lower ΔG) than the unmodified controls (ΔTm, 2.10 °C to 
13.06 °C, ΔΔG, -0.27 to -4.10 kcal/mol) for the n+2 to n+6 positions. By contrast, the 
FAAF modified full-length duplexes (NarI-FAAF-Full-dC) showed lower thermal and 
thermodynamic stabilities (lower ΔTm -6.20 °C to -15.61°C) and higher ΔΔG (1.77 to 
4.98 kcal/mol) values compared with those of the unmodified controls (Table 1).  
These results indicate that the lesion effect at n-1 to n+1 is minimal in both -2 
SMI and full TLS models.  Remarkably, no SMI is expected to form up to this point 
although some discernible differences appear at n+1. The lesion effect was quite 
consistent between n+2 and n+6/n+8. The thermal and thermodynamic stability of the -2 
SMI model over the control SMI was clearly due to the formation of a stable -2 SMI 
structure in which FAAF is stacked in the solvent protected bulge environment. By 
contrast, the negative thermodynamic effect on the full-length duplex models is 
contributed to the FAAF-induced S/B/W-conformational heterogeneity at both replication 
fork and duplex settings.      
FAAF-dT series:  Similar trend was observed in the dT series. Figure 23 shows 
the Tm and ΔG comparison between Full (NarI-FAAF-Full-dT; left) and -2 SMI (NarI-
FAAF-SMI-2-dT; right) models for the FAAF dT series as a function of increasing length 
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of primers. In the fully extended model, FAAF-modified duplex is thermally and 
thermodynamically less stable than the unmodified control (lower ΔTm -9.61 °C to -
19.40 °C and higher ΔΔG 2.42 kcal/mol to 5.02 kcal/mol). However, in the -2 SMI model, 
thermal and thermodynamic stabilities are significantly increased from n+2 to n+6 
(higher ΔTm 10.48 °C to 11.13°C and lower ΔΔG -2.18 kcal/mol to -2.88 kcal/mol) 
(Table 2). A higher thermal stability encountered for the dC (ΔTm 2.10 °C to 13.06 °C) 
over dT (ΔTm 0.85 °C to 11.13 °C) series -2 SMI indicates greater FAAF’s ability to 
form a stable bulge structure in dC than in dT. 
FABP-dC series:  Figure 24 shows the Tm and ΔG comparison between FABP-
modified full and -2 SMI models with increasing length of primers for the dC series. For 
FAAF, the fully extended FABP duplexes are thermally and thermodynamically less 
stable than the unmodified controls in the dC (NarI-FABP-Full-dC) (ΔTm -7.17 °C to -
14.47 °C) series. However, in the -2 SMI models, thermal and thermodynamic stability 
significantly increased from n+2 to n+6 (ΔTm 0.48 °C to 8.17 °C and ΔΔG -0.1 kcal/mol 
to -2.18 kcal/mol) (Table 3). 
FABP-dT series:  Figure 25 shows the Tm and ΔG comparison between FABP-
modified fully extended and -2 SMI models with increasing length of primers for the dT 
series. In the fully extended model, the FABP modified duplex destabilized the structure 
by ΔTm -7.32 °C to -15.25 °C and higher ΔΔG 2.16 kcal/mol to 4.27 kcal/mol (Table 4). 
The FABP modified duplex stabilized the -2 SMI bulge structure with higher ΔTm 
2.48 °C to 10.57°C and lower ΔΔG -0.20 kcal/mol to -2.73 kcal/mol. 
DSC 
We also conducted DSC experiments on FAAF-modified and unmodified control 
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-2 SMI TLS models in the dC and dT series. Figure 26 shows the overlays of plots of 
heat capacity change with increasing temperatures.  The maximum point of the Gaussian 
bell curves in the DSC thermograms represents duplex melting (Tm), and the areas under 
the curve denote transition enthalpy values (ΔH). The DSC results are independent of 
concentration and thus provide reliable thermal and thermodynamic parameters compared 
with those of UV melting.   
NarI-SMI-2-dC: Figure 26a shows an overlay of the unmodified dC series (NarI-
SMI-2-dC) from n-1 to n+6 as controls. The n-1 curve (cyan), which represents a 16/7-
ds/ss duplex, shows a broad curve with Tm of 35.1 °C and ΔH of -45.0 kcal/mol (Table 
5).  The curve shapes up nicely with one additional base (n) with Tm of 48.5 °C and ΔH 
of -48.5 kcal/mol.  Both Tm and ΔH have mostly stalled between n+1 and n+3. However, 
a significant increase existed at n+6 in Tm (57.3 °C) and ΔH (-120.9 kcal/mol). This DSC 
profile is inconsistent with the regular full-paired TLS cases, which generally show an 
incremental Tm/ΔH increases with increasing primer elongation.[37] Therefore, these 
results reflect the presence of a -2 bulge duplex formation.   
NarI-FAAF-SMI-2-dC: Figure 26b shows FAAF-modified -2 SMI bulge 
structure with increasing length of primers (n-1 to n+6). The major difference compared 
with the unmodified control (Figure 26a) indicated that Tm and ΔH increased 
progressively with increasing primer elongation from n-1 to n+3 TLS. In contrast with 
the unmodified control of -2 SMI, the curves for n to n+3 were all clustered together 
around the Tm of 48 °C (Figure 26a).  These DSC patterns resemble those obtained from 
melting of a regular full-length unmodified DNA duplex. These results support a unique 
stabilizing effect of the bulky FAAF though insertion and hydrophobic stacking.    
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NarI-SMI-2-dT: Figure 26c shows the DSC profiles for the unmodified -2 SMI 
TLS models in the dT series. The DSC profile trend was similar to that of the 
corresponding dC series (Figure 26a) with slightly better Tm dispersion for n to n+3.  A 
major exception demonstrated that the Tm and ΔH values are generally smaller in the dT 
series. 
NarI-FAAF-SMI-2-dT: Figure 26d shows the DSC curves for the FAAF-
modified -2 SMI TLS models. The profile trend was very similar to that of the 
corresponding FAAF-modified -2 SMI dC series with consistently smaller Tm and ΔH 
values.  The increase in ΔH was not as incremental as Tm in the dC series above. The 
melting Tm of the n-1 duplex was relatively lower (32.3 °C) than that (41.9°C) (Table 5) 
of the dC series.  This finding is ascribed to the presence of a weak T: A base pair instead 
of a more stable C: G base pair at the 3’-next flanking base, i.e., dT versus dC at N 
position (5’-CGGCG*CN-3’).    
Table 5 summarizes the thermal and thermodynamic parameters from the DSC 
results. Consistent with the UV melting results above, FAAF modified -2 SMI TLS 
models are more stable thermally and thermodynamically than the unmodified SMI 
controls.  The same trends are also verified with dC (ΔTm= 2.60 °C to 13.80 °C, ΔΔG= -
0.55 kcal/mol to -5.63 kcal/mol) over dT (ΔTm= 0.10 °C to 11.80 °C, ΔΔG= -0.17 
kcal/mol to -3.40 kcal/mol) series.  
Circular dichroism 
Circular dichroism (CD) is a sensitive technique for distinguishing different types 
of DNA duplexes.  For example, a typical B-form DNA helix displays a +/− “S-shape” 
ellipticity at 270 and 250 nm, respectively. The + intensity at 270 nm particularly 
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indicates the base stacking strength of a duplex DNA. We showed previously that AF- 
and AAF-modified duplexes exhibit lesion-induced ellipticity changes in the 300 nm to 
320 nm ranges depending on their S/B/W-conformational heterogeneity.[11, 28]  
Figure 27 compares the overlay of CD spectra of NarI-FAAF/FABP-SMI-2 
duplexes in the dC and dT series during the early stage of TLS, i.e., at n-1 (green), n 
(blue), and n+1 (red). A gradual increase of CD intensity in the FAAF modified dC series 
was observed at 270 nm in the n-1 → n → n+1 sequence, which indicates a progressive 
strengthening of base stacking.  This finding is contrasted to the lack of such change at n 
and n+1 in the dT series. The CD results may indicate a greater stacking for the dC series 
than for the dT. A similar dC versus dT comparison was conducted for the FABP adduct.  
Interestingly, FABP-modified SMI showed a gradual decrease of intensity at 270 nm in 
the n-1 → n → n+1 sequence, whereas the dT series exhibited slight changes in intensity. 
These CD results indicate that FABP and FAAF are involved in uniquely different 
mechanisms in the formation of -2 bulge adduct structures. 
Figure 28 shows the overlays of the CD spectra of FAAF-modified duplexes (red) 
with those of the unmodified controls (blue) for all TLS steps from n-1 to n+6 in both dC 
and dT series. In every case, FAAF-modified duplexes exhibited significant blue shifts 
compared with the unmodified controls. The effects were also greater for dC over dT 
series (dC series: 6 nm at n-1, 5 nm at n to n+3, 7 nm at n+6; dT series: 4 nm at n-1, 2 nm 
at n to n+3, 1 nm at n+6) (Table 6). These data suggest an adduct-induced DNA 
backbone bending. No significant changes existed in the CD intensity at 270 nm in both 
series throughout TLS except for the n+3/n+6 in the dT series, indicating a different 
pathway for the formation of -2 bulge adduct structures. 
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Figure 29 shows similar CD overlays for the FABP-modified duplexes (red) with 
those of the unmodified controls (blue) in both dC and dT series. We observed FABP-
induced blue shifts. However, they were generally smaller (dC series: 4 nm at n-1, 5 nm 
at n to n+3, 3 nm at n+6; dT series: 1 nm at n-1, 2 nm at n to n+3, 1 nm at n+6) (Table 6) 
than the FAAF series. These data indicated a relatively smaller DNA backbone bending 
in the FAAF case. In the dC series, the intensity at 270 nm was greater than that in the 
controls during the early stage of bulge formation (n-1 to n+1). However, subsequent 
TLS decreased from n+2 to n+6. By contrast, FABP in the dT series showed consistently 
low intensity at 270 nm relative to the unmodified controls with minimal blue shifts (1 
nm).  
Dynamic 
19
F-NMR 
NarI-FAAF-SMI-2-dC:  Figure 30 shows dynamic 
19
F NMR spectra of FAAF-
modified -2 SMI TLS models (n-1, n, n+1, n+3 and n+6) for the dC series (see Figure 2 
for all sequences). These -2 SMI duplexes exhibited a mixture of 
19
F signals, each 
representing a unique conformation with different electronic environments. The n+6 
represents a full -2 deletion duplex.  As discussed earlier, the G3*C bulge -2 structure was 
selected for the FAAF-modified 16/14-mer -2 SMI model based on 
1
H NMR and 
fluorescence results.   
The 
19
F NMR measurements were performed at 5 °C to 70 °C temperature range.  
All 
19
F signals coalesce into a sharp single peak above 60 °C at around −115 ppm, which 
represents a fast averaging FAAF-modified single-stranded 16-mer template. The data 
indicated that conformational heterogeneity exists at the n-1 stage, where the 3’-end of 
primer was located at one base before the lesion site and the heterogeneity was 
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maintained even at 40 °C. The heterogeneity became more complex as bulge formation 
was about to occur at n and n+1.  The bulge structure began maturing at n+3, and was 
completed at n+6. We have previously shown the 
19
F signals owing to the B-, S-, and W- 
conformation of a fully paired FAAF-modified duplex to appear at −115.0 to −115.5 ppm, 
−115.5 to −117.0 ppm and −116.5 to −118.0 ppm ranges, respectively.[11] As mentioned 
above, the −115 ppm signals at the coalescence temperatures are attributed to the 
denatured single strand in which the 
19
F tag is fully exposed to the solvent.  This signal is 
usually in sync with B-type conformer, in which the 
19
F tag is exposed and thus shifted to 
downfield. The shielded signal at −116.3 ppm can arise from the Van der Waals 
interactions between the 
19
F tag and neighboring base pair as in the S- or W-conformer. 
However, the current model is a -2 bulge structure without discernible major or minor 
groove configurations. As a result, two major 
19
F signals at −115.5 and −116.4 ppm at 
20 °C in the n+6 duplex (e.g., completed -2 bulge structure) could be assigned to either 
“lesion-exposed” (B-SMI) or “lesion-stacked” (S-SMI) conformers (Figure 1). A small 
signal at −114.8 ppm was observed at lower temperatures (5 °C to 10 °C) and coalesced 
with the B-SMI signal at 20 °C. The identity of this minor thermally unstable conformer 
could not be characterized. The B- and S-SMI designation can only be made at the n+1, 
n+3, and n+6 duplexes, where two well-defined signals were obtained. The conformers 
observed for the n-1 to n+1 duplexes comprise a mixture of narrow and broad signals, 
which could be assigned to various conformationally flexible species, including the B- 
and S-SMI originated from the immaturity of the corresponding -2 bulge structures. 
NarI-FAAF-SMI-2-dT: Similar dynamic 19F NMR experiments were performed 
for the dT series (Figure 31). We observed a much greater heterogeneity at the n-1 and n 
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duplexes than at the dC series; at least four different conformations were found in the 
−113 ppm to −117 ppm range. This 19F signal complexity could be ascribed to numerous 
intermediate conformers possibly near the lesion at the beginning of bulge formation.  
The spectral pattern was simplified at n+1 presumably because of an increased 
conformational stability, indicating a near completion of the G3*C bulge structure. A 
similar pattern persisted at n+3 with one major and one minor signal at −115.3 and 
−116.2 ppm, respectively. These results indicate that a primer elongation of three bases 
after the lesion site is enough to produce a stable -2 SMI and the pattern continue into a 
full bulge duplex at n+6 with slight changes.   
In the dC series, the major downfield and minor upfield signals in the n+6 duplex 
were assigned to the solvent exposed B- and inserted stacked S-SMI conformers, 
respectively. As expected, the minor upfield S-SMI signal gradually coalesces into the B-
SMI signal at 55 °C. The merged signal broadened at 60 °C and then sharpened at 70 °C 
owing to the denaturation to a single-stranded template. An exclusive presence of the B-
SMI-2 in the dT series is contrasted to a 59:41 mixture of B- and S-SMI observed for the 
dC series. The results are consistent with the thermal and thermodynamic instabilities 
observed from UV melting and DSC. The 20 °C spectra of the n+6 SMI were simulated 
by line fittings (Figure 34). The simulation results showed 59% B-SMI (−115.5 ppm) and 
41% S-SMI (−116.3 ppm) conformer in the dC series and 86% B-SMI (−115 ppm) and 
14% S-SMI (−116 ppm) conformers in the dT duplex.  
NarI-FABP-SMI-2:  Figures 35 and 36 show the dynamic 
19
F NMR spectra of 
the FABP- TLS for the formation of a -2 SMI (n-1, n, n+1, n+3, n+6) in the dC and dT 
series. Unlike the FAAF duplex cases, FABP exhibited a relatively simple 
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conformational heterogeneity throughout TLS. The simplicity is more pronounced in the 
dC series relative to the dT. The n+6 duplex exhibited 86: 14 ratio of the B- and S-SMI 
conformers. One major signal dominated in the n+1to n+6 sequence at 5 °C. However, a 
small peak at around −117 ppm increased along with the temperature increase in n+3 and 
n+6 duplexes. In particularly, two major peaks existed in n+6 at 50 °C, then exchanged, 
and eventually merged at 65 °C. Unlike the dC series, the dT series simplified as one 
major peak from n-1 to n+6. Except at 40 °C, a second minor peak showed up at n+1, 
n+3, and n+6, although two peaks merged at 60 °C.  
Imino proton NMR 
Figures 32 and 33 show the dynamic imino proton spectra of the NarI-FAAF-
SMI-2-dC and NarI-FAAF-SMI-2-dT series under the same primer elongation and 
temperature conditions.  Generally, A:T and G:C imino proton signals owing to 
Watson−Crick base pairs appear in the 13 ppm to 14 ppm and 12 ppm to 13 ppm ranges, 
respectively. The imino proton signal intensity decreases with increasing temperatures 
caused by fast proton exchanges.  As expected, the G: C imino signals are more resistant 
to temperature than the A: T ones. Notably, the imino protons of the lesion-modified dG 
in the highly shielded 11 to 12 ppm range were relatively resistant to temperature and 
solvent exchange. This finding is particularly true for n+3 and n+6 cases in both dC and 
dT series.  Similar imino proton spectral transitions were obtained with the FABP-
modified TLS system (Figures 37 and 38).  In summary, the imino proton NMR results 
generally support the sequence dependent conformational heterogeneity observed in the 
19
F NMR experiments.    
Surface plasmon resonance  
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We used surface plasmon resonance (SPR) to examine the binding interactions of 
the modified 16-mer templates as a function of primer length during TLS involvement in 
the formation of -2 bulge structures. The FAAF/FABP modified sequences were either 
full length or -2 SMI duplexes in the dC and dT series.  Figures 44 and 45 show the SPR 
set up used in the present study. The procedure is similar to that reported previously,[38] 
which involves modified biotinylated 16-mer sequence on a streptavidin-coated 
carboxymethylated surface with addition of various primers as flow-through analytes. 
Biotinylated NarI 16-mer sequence:  FAAF/FABP modification was performed 
as usual with 5’-biotin labeled 16-mer sequence to prepare the TLS samples used for 
NMR/CD and thermodynamic experiments.  The HPLC profiles of the biotin-16-mers are 
expected to differ because of biotin’s hydrophobicity. No HPLC separation of adducted 
biotinylated oligonucleotides has been reported in the literature. After repeated attempts, 
we found a system (see the Materials and Methods) that allowed separation of FAAF 
modified biotinylated sequences in the dC and dT series in less than 20 and 35 min, 
respectively (Figures 40a and 40b). Three mono-FAAF-modified oligos were separated 
in the 12 min to 17 min range. Mono-FABP modified oligos were similarly separated in 
45 -55 min (Figure 41).    
The modified biotinylated 16-mer sequence templates were characterized by 3’-5’ 
exonuclease digestion followed by MALDI-TOF. Figure 42a shows the spectra obtained 
from peak 2 of the dC series, which displayed the parent ion at 5424 m/z before digestion 
and major fragments at 3625 and 3336 m/z upon digestion. These findings indicated 
FAAF modification at G3. Figure 42b shows the spectra obtained for peak 2 in the dT 
series, which exhibited the parent ion at 5439 m/z and major persistent fragments at 3625 
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and 3336 m/z. The results indicated FAAF modification at G3. FABP modified dC/dT 
series was similarly characterized. Figure 43a shows the following spectra of the dC 
series: the parent ion at 5370 m/z before digestion and a persistent peak at 3282 m/z, 
which indicated G3 modification. Figure 43b shows the following spectra of the FABP 
modified dT series: the parent ion at 5385 m/z and a persistent fragment ion 3283 m/z, 
which indicated G3 modification.  
SPR setup: The SPR experiments aimed to measure real-time association 
between template and complementary strands in the absence of a polymerase The 
FABP/FAAF-G3 modified 16-mer NarI 16-mer sequences characterized above were 
individually coated on the streptavidin pre-immobilized chip. Binding strengths were 
measured by injecting primers of different lengths (Figures 44 and 45). Each elongation 
required different concentrations of complementary strands to achieve steady-state 
associations: (n-1) 25 nM, (n) 50 nM, (n+1) 75 nM, (n+2) 100 nM, (n+3) (n+6) (n+8) 150 
nM. After reaching a steady state, primers were washed off by a running buffer, and the 
system was regenerated by NaOH addition. Figure 44 shows the sensorgrams obtained 
from the FAAF-modified TLS systems either in the fully extended (top) or -2 SMI 
(bottom) as a function of primer length. Measurements were conducted in both dC (left) 
and dT (right) series. A typical binding affinity of KD (ka/kd) kinetics could not be 
applied in the present case because the association rate constant (ka) is concentration 
dependent, yet we used different concentrations for each length primer. DNA strand 
binding is also not an amenable traditional KD designed for weak macromolecular 
bindings. However, all the experimental conditions were kept identical for each primer. 
Thus, the response units (RUs) and more importantly, the dissociation rate constant (kd) 
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could be used to compare the binding strengths during a simulated TLS. The results 
should provide the extent of lesion effect during the TLS. As such, we conducted fitting 
of kd curves (Figures 48 and 49) using Scrubber (BioLogic Software). The resultant kd 
values are summarized in Tables 7 and 8.  
Unmodified control models: In the fully extended model (Figures 44a and 44b), 
minimal changes occurred with increasing primer lengths at n-1 (16-/7-mer) and n (16-/8-
mer), but a significant increment of RU values began from n+1 (16-/9-mer) onwards.  In 
contrast with -2 SMI models (Figures 44e and 44f), abrupt changes in RU intensities (20 
RU to 35 RU) and faster dissociations were observed between n (16-/8-mer) and n+2 (16-
/10-mer) steps. These results support formation of a -2 bulge structure during the TLS 
steps.  However, the bulge, G3C or CG3, formed for the unmodified sequences is 
unknown. In both full and -2 SMI scenarios, the nature of the ‘N’ base exhibited a 
minimal effect on binding characteristic, i.e., comparison between dC (Figures 44a, 44c, 
44e and 44g) and dT (Figures 44b, 44d, 44f, and 44h) series.   
FAAF modified fully extended TLS: The FAAF-modified full length dC series 
(Figure 44c) exhibited a gradual increment of RU during the TLS, i.e., n-1 to n+8.  Faster 
dissociation rates compared with the unmodified controls, particularly on n+1 to n+3, 
indicated weak binding strength around the lesion.  Notably, a significant increase of RU 
(up to 20 RU) occurred at the lesion site n. By contrast, in the full-length dT series 
(Figure 44d), the RU intensities were significantly suppressed throughout TLS, with the 
effect much greater in the bulge area (n-1 to n+2).  The dissociation rates up to n+3 were 
also much faster than those of the unmodified controls.   
FAAF modified -2 SMI TLS:  The FAAF-modified -2 SMI models (Figures 44g and 44h) 
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showed fairly gradual increment of RU with increasing primer lengths. The overall RU 
intensities were greater for dC (Figure 44g) over the dT (Figure 44h) series.  Interestingly, 
the overall sensorgram patterns of the FAAF -2 SMI are quite similar to those of the 
unmodified fully extended (Figures 44a and 44b).  Significant increases also occurred in 
dissociations rates. These results suggested the strengthening of the template-primer 
binding affinities by the FAAF-lesion at G3.  For example, the binding strength of FAAF-
modified SMI at n+1 (16-/9-mer, pink) was increased by 1.92-fold (2.67/1.39) and 3.30-
fold (35/10.6) relative to the unmodified SMI controls for the dC and dT series, 
respectively. The lesion effect persisted at n+2 (30.3-fold, 3/0.099) (26.5-fold, 
14.8/0.559), n+3 (7.58-fold, 0.311/0.041) (46.2-fold, 8.08/0.175), and n+6 (7.8-fold, 
0.146/0.0188) (3.2-fold, 0.0898/0.0279) for the dC and dT series. 
FABP model series. We conducted an identical set of SPR experiments as above 
except that the lesion was switched to FABP. The two model systems exhibited a 
basically similar SPR binding and dissociation characteristics on both unmodified 
controls (Figure 45a, 45b, 45e, and 45f) and FABP modified fully extended (Figures 45c 
and 45d) and -2 SMI (Figure 45g and 45h) models. However, the RU intensities of the n 
to n+2 were notably suppressed by FAAF compared with FABP in the dT series (Figure 
44d vs. Figure 45d and Figure 44h vs. Figure 45h) for full length extended and -2 SMI, 
respectively. Table 8 shows the binding strength for FABP modified -2 SMI that 
increased relative to the following unmodified controls: 1.21-fold (2.22/1.83) and 3.31-
fold (33/9.98) at n+1; (209-fold, 2.93/0.014) (39.6-fold 15.9/0.4017) at n+2; (6.57-fold, 
0.4207/0.064) (58.3-fold, 7.46/0.128) at n+3; (6.8-fold, 0.1914/0.02808) (2.63-fold, 
0.0792/0.0301) at n+6. 
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Figure 46 overlays the steady-state normalized sensorgrams derived from four 
TLS models: unmodified full and -2 SMI; FAAF-modified full length and -2 SMI. The 
binding strength can be gleaned directly from the shapes of these dissociate curves. The 
binding strength at n+1 were in the order of unmod full > FAAF -2 SMI > FAAF full ~ 
unmod -2 SMI; FAAF -2 SMI > unmod full > FAAF full > unmod -2 SMI at n+2; FAAF 
-2 SMI > unmod full > unmod -2 SMI > FAAF full at n+3; FAAF -2del ~ unmod full ~ 
FAAF -2 SMI > unmod -2 SMI at n+8/n+6. In the dT series, the unmodified full model 
was most stable: unmod full > FAAF full > FAAF -2 SMI > unmod -2 SMI at n+1; 
unmod full > FAAF -2 SMI > FAAF full > unmod -2 SMI at n+2; unmod full > FAAF -2 
SMI > FAAF full > unmod -2 SMI at n+3; unmod full ~ FAAF full > FAAF -2 SMI > 
unmod -2 SMI at n+8/n+6. 
Figure 47 overlays the steady-state normalized sensorgrams derived from four 
TLS models: unmodified full and -2 SMI; FABP-modified full length and -2 SMI. In the 
dC series, the binding strength at n+1 were in the order of unmod full > FABP -2 SMI > 
FABP full = unmod -2 SMI; unmod full = FABP -2 SMI > FABP full > unmod -2 SMI at 
n+2; unmod full ~ FABP -2 SMI > FABP full > unmod -2 SMI at n+3; unmod full ~ 
FABP full ~ FABP -2 SMI > unmod -2 SMI at n+8/n+6. In the dT series, the unmod full > 
FABP full > FABP -2 SMI > unmod full at n+1; unmod full > FABP -2 SMI > FABP 
full > unmod -2 SMI at n+2; unmod full > FABP -2 SMI > FABP full > unmod -2 SMI at 
n+3; unmod full ~ FABP full ~ FABP -2 SMI ~ unmod -2 SMI at n+8/n+6.  
 
Discussion 
We conducted a series of systematic structural studies to probe the conformational 
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mechanisms of arylamine-induced -2 frameshift mutation frequently observed in the E. 
coli NarI sequence (5’---CCGGCG*CN---3’; N= dC and dT) during translesion synthesis 
(TLS). We used two well-characterized fluorinated DNA lesions, FAAF and FABP, as 
models for carcinogen 2-aminofluorene and 4-aminobyphenyl. The objective of the 
present study was to determine the conformational consequences of lesion structures (size, 
bulkiness, and overall topology) and the 3’-next flanking base sequence N (dC or dT) in 
generating a -2 slipped mutagenic intermediate (SMI), the bulge structure responsible for 
AAF-induced -2 frameshift mutagenesis. We previously showed that the bulky N-
acetylated and planar AAF utilizes a mixture of S/B/W-conformations, whereas the less 
bulky N-deacetylated and non-planar ABP exists mostly in B-type conformation.[4, 11] 
The AAF-induced conformational heterogeneity was largely dependent on the nature of 
flanking bases around the lesion (NG*N sequence context), which in turn led to different 
mutational and repair outcomes. Earlier, we showed that the AF-modified -2 SMI 12-mer 
duplex with N=C (CTCG1G2CG3*CCATC) adopts exclusively an “inserted” stacked S 
conformer (S-SMI), whereas the same duplex with N=T (CTCG1G2CG3*CTATC) exists 
in a mixture of S-SMI and the “solvent exposed” B-type B-SMI conformers.[28] These 
results explain why the unusual frameshift vulnerability of the AF lesion at G3 is dictated 
by the nature of the next flanking base N (C >> T). However, the detailed conformational 
mechanisms of SMI formation have yet to be elucidated, which is the subject of the 
present study.  
We hypothesized that the conformational, thermodynamic, and binding stabilities 
of -2 SMI are critical factors to determine the efficacy of frameshift mutations in the NarI 
sequence context. In this study, we examined the conformational details of how a bulky 
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lesion favors a certain specific type of bulge structure during TLS. As mentioned in the 
Results section, the Streisinger-based -2 bulge formation in the NarI sequence would 
allow two possible -2 SMI structures, G3*C or CG3* looped out, albeit producing an 
identical -2 deletion daughter strand. Basing on the NMR and fluorescence results, we 
selected the G3*C and CG3* models for FAAF or FABP, respectively (Figure 2). We 
utilized the fluorine-tagged FAAF and FABP as model lesions for AAF and ABP to 
obtain dynamic 
19
F NMR, which allows the measurement of conformational 
heterogeneity. FAAF represents an N-acetylated 2-aminofluorene and is therefore rigid, 
bulky, and coplanar. By contrast, the N-deacetylated FABP is conformationally flexible, 
less bulky, and nonplanar. We performed in two different 3’-next flanking base sequence 
contexts for the dC and dT series [CTCTCG1G2CG3CNATCAC-3’ N =C: dC series or 
N=T: dT series; G3*=FAAF or FABP] (Figure 2b, c). The choice for these sequences was 
based on previous mutation studies, which indicated that the bulky lesion AAF at G3 
position induces -2 deletion mutations at the highest frequency, and their propensity is 
modulated by the nature of the nucleotide in the N position (C >> T). We acquired a 
combination of biophysical parameters to elucidate the conformational mechanism for the 
formation of -2 SMI in a chemically simulated TLS. Figure 4 presents a model for FAAF 
and FABP-induced -2 frameshift mutagenesis on the basis of our findings in this study. 
This schematic diagram shows the progression of lesion-induced conformational 
heterogeneity during a simulated TLS (n-1 to n+6) (Figure 39).  
Overall TLS: At n-1, the modified G3* at the ds/ss replication fork is likely to exist in a 
mixture of syn and anti-glycosidic and closely related conformations. This phenomenon 
is illustrated in Figure 39 in which conformationally flexible lesions (FAAF or FABP) 
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are shown in multiple red-dotted ovals (labeled A). This is supported by a complex 
combination of sharp and broad signals observed in the 
19
F NMR spectra (Figures 30, 31, 
35, and 36). Upon addition of the correct C, the modified G3* will produce an unstable 
G3*: C base pair at the lesion site n (B). The presumed G3*: C pair (B) is expected to be 
less stable than the regular Watson-Crick-based G:C pairing because the bulky arylamine 
at the C8 of dG tends to favor a syn-glycosidic conformation. Such instability and 
heterogeneity can cause a polymerase to stall, so a slippage occurs, or the DNA synthesis 
could be completely blocked for recruitment of bypass polymerases. The 
19
F NMR data 
support the presence of a complex conformational heterogeneity at both pre (n-1) and 
lesion (n) sites.  
The above-mentioned G3*: C pair undergoes two different slippage pathways via 
single-base ‘C’ or two-base ‘CG’ from the 3’-terminal of the 8-mer primer, which yields 
CG3* and G3*C -2 bulge SMI structures C and D, respectively (Figure 39). As mentioned 
earlier, G3*C SMI (D) is preferred by FAAF, whereas CG3* SMI is favored by FABP. As 
evidenced by NMR, in both cases, the formation of -2 bulge significantly shapes up at 
n+1 (C and E for ‘C’ and ‘CG’ slippage, respectively) (see Figures 30, 31, 35 and 36). 
The conformational flexibility and instability involving a bulge formation at n-1 ~ n+1 
sites are reinforced by little thermal (ΔTm) and thermodynamic (ΔΔG) changes, a lower 
surface resonance (SPR) response units (RU), and faster dissociation rates (kd) relative to 
the unmodified controls (Figure 20–26, Tables 1–5 and Tables 7-8).  
Conformation rigidity improves as the length of the primer increases, which is 
again evidenced by the dynamic 
19
F NMR spectra. The continued progressive TLS from 
n+1 produced two very different -2 SMI conformers at n+3 and ultimately in the fully 
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matured n+6 (F and G). They are the B-SMI conformer (F1 and G1 for FABP and FAAF, 
respectively) in which the lesion is solvent exposed as in the B-type conformation, or S-
SMI (F2 and G2 for FABP and FAAF, respectively) in which the lesion is solvent 
protected and inserted/stacked with the presumed syn-glycosidic G3*. Figure 39 inset 
illustrates the progressive nature of lesion conformational rigidity during the simulated 
TLS, i.e., light dotted > solid dotted > solid lines as a function of primer lengths. For 
example, the B-SMI (light dotted) is likely to be conformationally more flexible than the 
base stacked S-SMI (solid dotted) at n+1(as in C and E), and the development continues 
to improve the rigidity for B- and S-SMI at fully paired n+6 duplexes (solid dotted and 
solid lines in F and G, respectively). The multiplicity of light dotted ovals indicates 
conformational flexibility within the syn or anti-glycosidic conformers. The progressive 
nature of bulge stability is also supported by appropriate variances in Tm and ΔH values 
(UV-melting and DSC), as well as the SPR binding characteristics (RU) and dissociation 
rates (kd) during bulge formation (Figure 20–26, Tables 1–5 and Table 7-8).  
Lesion Effect: The structures of FABP and FAAF are generally similar in that 
both are C8-substituted dG lesions, but they differ in two major ways: 1) FABP lacks a 
bridging methylene carbon, so it is less coplanar than FAAF, and 2) FAAF is N-
acetylated and is thus steric near the adduction point and perturbs the DNA helix. We 
found that FABP prefers, on average, B-SMI (~90% B) over S-SMI (5-10%) regardless 
of the nature of the 3’-flanking base N (dC or dT). This is in contrast to FAAF, which 
showed a mixture of B-SMI (59% and 86%) and S-SMI (41% and 14%) for the dC and 
dT series, respectively. These results indicate the importance of the relative nonplanarity 
of FABP over FAAF in producing a great amount of S-SMI. Our 
19
F NMR data are in 
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general agreement with those of Milhe’s 1H NMR study of an AAF-modified NarI-based 
11/9-mer duplex (5’-ACCGGCG*CCACA-3’)(5’-TGTG--GCCGGT-3’), which showed 
80% of syn-modified dG* S-SMI conformation.[36] A similar study by Mao et al.[5] 
showed an exclusive presence of stacked S-SMI conformation for N-deacetylated AF in 
the NarI-based 12/10-mer duplex (5’-CTCGGCG*CCATC-3’) (5’-GATGG--CCGAG-
3’). The latter appears to be in direct contrast to that observed for the similarly N-
deacetylated ABP lesion in the present study. No NMR structures are available yet on 
ABP in the -2 SMI duplex, so a direct comparison is not possible. Nonetheless, our 
results support the importance of lesion coplanarity in producing S-SMI. The significant 
reduction in the population of the stacked syn-G* in FAAF (14%–41%) over FABP 
(~90%) in the NarI-based -2 deletion duplexes indicates the importance of the ‘N-acetyl 
factor’ and lesion coplanarity in producing -2 bulge S-SMI.  
FAAF and FABP-modified -2 SMI at n+6 showed consistently greater thermal 
and thermodynamic stabilities relative to the fully paired counterparts (Tm 10.5 °C to 
11.7 °C and ΔΔG −2.6 to −3.2 kcal/mole for FAAF and Tm 7.5 °C to 8.0 °C and ΔΔG 
−1.1~ −2. kcal/mole for FABP). This is in contrast to the consistent decreases in thermal 
and thermodynamic stabilities observed for the corresponding fully paired 
complementary duplexes (Tables 1–4) examined in the present and previous studies. The 
thermal stability increases as the bulge formation matures from n+1 to n+6, and the trend 
persists for both FABP and FAAF throughout TLS, as illustrated in Figure 39 (Tables 1–
4). A gradual increase in thermal stability, however, seems to be inconsistent with the 
striking conformational differences in B- and S-SMI observed between FAAF and FABP. 
The result indicates that lesion stacking and bulge formations are both important factors 
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that contribute to the stability of -2 bulge duplexes. 
Sequence Effect on Bulge Formation: Another interesting finding is the effect 
of the 3’-next flanking N base (dC vs. dT series, Figure 39) on bulge formation, i.e., 
FABP at n+6 (F) prefers, on average, B-SMI (86% and 94% B) over S-SMI (14% and 
6%) for the dC and dT series, respectively. In other words, no discernible difference in 
conformational population was observed for FABP between the dC and dT series. 
However, that was not the case for FAAF, which showed a significant S/B-population 
difference between the two series: 59%: 41% of B- and S-SMI for the dC series and 
86%:14% of B- and S-SMI for the dT series. These results are consistent with our 
proposed model (Figure 39), which contends the importance of the “lesion coplanarity” 
and “N-acetyl” factor. For example, the planar and hydrophobic lesion in the FAAF-
induced S-SMI (G2) maintains direct molecular interactions with the N-N’ base pair in 
the bulge structure. However, no such contacts are likely for the FABP-induced CG3* 
bulge S-SMI (F2). As a result, the N-N’ base pair has a much greater influence on the S-
SMI population (41% and 14% for the dC and dT series) of the CG3* bulge FAAF 
pathway (G) than that (10% and 5% for the dC and dT series) of the G3*C bulge pathway 
FABP (F). The hydrogen bond strength of the N-N’ base pair clearly plays a role, so the 
three hydrogen-bonded C: G at N position enables a stacking interaction with the lesion 
better than the two hydrogen-bonded T:A base pairs. Furthermore, the stability of the N-
N’ base pair helps docking and stacking of the bulky hydrophobic lesion into the small 
pocket of -
 The DSC results are 
also consistent with SPR binding affinity data, which exhibited consistently high RU 
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intensities and slow dissociation rates (kd) throughout TLS in both FAAF and FABP. The 
effect of the 3’-next flanking base sequence is also reinforced by CD spectra (Figure 27), 
in which the FAAF-dC series showed a gradual increase in ellipticity at 270 nm during n-
1 → n → n+1 progression. The CD results indicated a progressive strengthening of base 
stacking. However, no such change was noted in the dT series. A similar set of results 
was obtained for FABP. Taken together, the CD results indicate the effect of the 3’-ext 
flanking base on lesion stacking within the -2 bulge structures. 
‘C’ versus ‘CG’ Streinger Slippage: Finally, our study sheds some light on a 
fundamental question as to why FAAF and FABP undergo unique slippage during TLS 
(‘CG’ and ‘C’ for the B→C and B→D pathways, respectively). As detailed in the Results 
section above, the available 
1
H NMR, mass, and fluorescence results facilitated the CG3* 
and G3*C -2 bulge as the most likely scenarios for the respective FABP- and FAAF-
induced TLS pathways. The conformational stability of the G*: C pair at the lesion site n 
(B) appears to be a major determining factor. In fully paired complementary duplexes, 
the bulky N-acetylated FAAF prefers syn-glycosidic G* conformation, whereas FABP is 
N-deacetylated and conformationally flexible, thus exists mostly in the anti-glycosidic B-
type conformer. A similar conformational preference is expected at the ss/ds replication 
fork. As a result, syn-FAAF-G*: C is expected to produce great conformational instability, 
which triggers a two-base (‘CG’) slippage. By contrast, the flexible anti-FABP-G*: C is 
less of a trigger; it induces a one-base ‘C’ slippage. Once the slippage pathway is defined, 
subsequent primer elongation continues to produce respective -2 bulge structures (F and 
G), each resulting in a mixture of B- and S-SMI conformations. 
We previously studied the effect of the 3’-next flanking base (N= dC or dT) by 
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using FAF-modified NarI-based 12/10-mer -2 deletion [(5’-CTCGGCG*CNATC-3’) (5’-
GATNGCCGAG-3’)] duplexes. The results showed that the NarI-dC/-2 deletion duplex 
exhibits mostly an S-SMI conformer, whereas the NarI-dT/-2 deletion duplex exists as a 
mixture of the S- and B-SMI conformers. Schorr and Carell have conducted an elegant 
primer extension study coupled with MALDI-TOF[26] mass spectrometry to show that 
frameshift formation is triggered by the unstable base pairing of the AAF lesion with the 
correct incoming dC. Such configurations have been observed in both replicative and 
bypass polymerases, and the stability of bulged-out structures and the subsequent 
elongation determines the propensity for frameshift mutagenesis. To this end, we 
conducted studies on FAAF-modified NarI-sequence corresponding to −1, −2, and −3 
deletion duplexes.[27] These SMIs existed in a mixture of B- and S-SMI conformers, 
with the population of the S conformer and the thermodynamic stability in the order of 
−1 > −2 > −3. The results indicate the good stability of S-SMI, which supports the results 
of the aforementioned work of Schorr and Carell, as well as emphasizes the importance 
of SMI stability for frameshift mutations. 
 
In summary, we presented a conformational TLS model for arylamine-induced -2 
frameshift mutagenesis in the E. coli NarI mutational hot spot sequence. Figure 39 shows 
a cartoon depiction of the conformational details of the proposed model, which are based 
on a combination of systematic spectroscopic (
19
F NMR/CD), thermodynamic (UV-
melting/DSC), and affinity binding (SPR) data. Our findings indicate that the Streisinger-
based -2 bulge formation is triggered by several factors, including the adduct structure 
and conformation at the replication fork, as well as the nature of base sequences 
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surrounding the lesion site. The extent of conformational stability of the G3*: C pair 
determines the nature of a slippage (‘CG’ vs. ‘C’), and subsequent primer elongation 
yields the respective -2 CG3* or G3*C bulge structures. Each bulge structure exists in a 
mixture of B-SMI and S-SMI, in which the bulky lesion is located outside the bulge 
(“solvent accessible”) and inserted into the bulge (“solvent protected”). B-/S-SMI 
population ratios are dependent on various structural factors, such as the size, bulkiness 
(‘N-acetyl), coplanarity, and overall topology of a lesion, as well as the 3’-base sequence 
(N) next flanking to the lesion site.  
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Figure legends 
Figure 1: (a) Chemical structures of FAF/FAAF/FABP modified guanines (b) major 
groove views of prototype B-, S- and W- conformers of arylamine-DNA in CPK model. 
Color code: DNA duplex, gray; arylamine lesion, red; modified-dG, cyan; dC opposite 
the lesion site, green.  
Figure 2: Proposed translesion synthesis (TLS) models for FAAF and FABP of NarI 
dC/dT sequence. (A) full length extended model with full length primers (B) FAAF 
modified slipped mutagenic model with G3C -2 deletion primers (C) FABP modified 
slipped mutagenic model with CG3 -2 deletion primers. The red guanine G3 position was 
modified by FAAF/FABP adduct, whereas unmodified guanine as control. The blue base 
in the template can be C or T, named as dC or dT series, respectively. The blue base in 
the primers is G or A which pairs with C or T. 
Figure 3: (a) Slippage model cited from Hoffmann, G. and Fuchs, R. P. Chemical 
Research in Toxicology 1997 (b) Slippage model for the -2 frameshift mutation by 
FAAF/FABP adduct on the hot spot NarI sequence (5’-GGCGCN-3’).  
Figure 4: Proposed mechanism of -2 deletion bulge formation of AAF/AF/ABP modified 
NarI dC/dT series.    
Figure 5:  (a) Chromatogram profile of the reaction mixture of FAAF modified 16-mer 
NarI sequence. The mono-(G1, G2, G3), di- and tri- FAAF adducts eluted at the 11-14, 15-
18 and 19 min were purified by reverse-phase HPLC using C18 column and 
characterized by MALDI-TOF (b) Photodiode array UV/Vis spectra of seven peaks, in 
which the intensity of the 300-325 nm shoulders indicate the number of the adducts: 
mono-, di, and tri-FAAF adducts.  
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Figure 6: FAAF modified NarI dC sequence chromatogram profiles from reaction 
mixture. (a) 25 min gradient method developed in the present project (b) 90 min method 
was used in previous paper (Jain et al., Nucleic Acids Research, 2012, Vol. 40, 3939-
3951).   
Figure 7: (a) Chromatogram profile of the reaction mixture of FABP modified 16-mer 
NarI sequence. The mono-(G1, G2, G3), di- and tri- FABP adducts eluted at 19-24, 34-38 
and 42 min were purified by reverse-phase HPLC using clarity column and characterized 
by MALDI-TOF (b) Photodiode array UV/Vis spectra of seven peaks. The shoulder 
intensity at 300-325 nm indicate the number of the adducts: mono-, di, and tri-FABP 
adducts.  
Figure 8:  MALDI spectra of 3’ and 5’ enzyme digestions of FAAF dC peak 1 sample. 
Molecular weight of DNA fragments of FAAF modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 5017 m/z at 0s corresponds to the FAAF modified 16-
mer dC template. 2310 and 1981 m/z correspond to the modified lesion site of G1 (b) 5’ 
digestion profiles of 5017 m/z ion at 0 s shows the whole sequence and 3832 m/z peak 
corresponds to the fragment near the lesion G1. Both 3’ and 5’ digestions show peak 1 as 
G1.  
Figure 9:  MALDI spectra of 3’ and 5’ enzyme digestions of FAAF dC peak 2 sample. 
Molecular weight of DNA fragments of FAAF modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 5017 m/z at 0s corresponds to the FAAF modified 16-
mer dC template. 3218 and 2929 m/z correspond to the modified lesion site of G3 (b) 5’ 
digestion profiles of 5017 m/z ion at 0 s shows the whole sequence and 2883 m/z peak 
corresponds to the fragment near the lesion G3, 2594 m/z peak indicates the G3 lesion site. 
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Both 3’ and 5’ digestions show peak 2 as G3.  
Figure 10:  MALDI spectra of 3’ and 5’ enzyme digestions of FAAF dC peak 3 sample. 
Molecular weight of DNA fragments of FAAF modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 5017 m/z at 0s corresponds to the FAAF modified 16-
mer dC template. 2599 and  2310 m/z correspond to the modified lesion site of G2 (b) 5’ 
digestion profiles of 5017 m/z ion at 0 s shows the whole sequence and 3542 m/z peak 
corresponds to the fragment near the lesion G2, 3214 shows the G2 lesion site. Both 3’ 
and 5’ digestions show peak 3 as G2.  
Figure 11: MALDI spectra of 3’ and 5’ enzyme digestions of FAAF dT peak 1 sample. 
Molecular weight of DNA fragments of FAAF modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 5031 m/z at 0s corresponds to the FAAF modified 16-
mer dT template. 2310 and 1981 m/z correspond to the modified lesion site of G1 (b) 5’ 
digestion profiles of 5031 m/z ion at 0 s shows the whole sequence and 3844 m/z peak 
corresponds to the fragment near the lesion G1. Both 3’ and 5’ digestions show peak 1 as 
G1.  
Figure 12:  MALDI spectra of 3’ and 5’ enzyme digestions of FAAF dT peak 2 sample. 
Molecular weight of DNA fragments of FAAF modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 5031 m/z at 0s corresponds to the FAAF modified 16-
mer dT template. 3218 and 2928 m/z correspond to the modified lesion site of G3 (b) 5’ 
digestion profiles of 5031 m/z ion at 0 s shows the whole sequence and 2896 m/z peak 
corresponds to the fragment near the lesion G3. Both 3’ and 5’ digestions show peak 2 as 
G3.  
Figure 13: MALDI spectra of 3’ and 5’ enzyme digestions of FAAF dT peak 3 sample. 
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Molecular weight of DNA fragments of FAAF modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 5031 m/z at 0s corresponds to the FAAF modified 16-
mer dT template. 2599 and 2310 m/z correspond to the modified lesion site of G2 (b) 5’ 
digestion profiles of 5031 m/z ion at 0 s shows the whole sequence and 3844 , 3555 m/z 
peaks correspond to the fragment near the lesion G2. Both 3’ and 5’ digestions show peak 
3 as G2.  
Figure 14: MALDI spectra of 3’ and 5’ enzyme digestions of FABP dC peak 1 sample. 
Molecular weight of DNA fragments of FABP modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 4963 m/z at 0s corresponds to the FABP modified 16-
mer dC template. 1929 m/z corresponds to the modified lesion site of G1 (b) 5’ digestion 
profiles of 4963 m/z ion at 0 s shows the whole sequence and 3776 m/z peak corresponds 
to the fragment near the lesion G1, 3487 m/z  peak indicates the G1 lesion site. Both 3’ 
and 5’ digestions show peak 1 as G1.  
Figure 15: MALDI spectra of 3’ and 5’ enzyme digestions of FABP dC peak 2 sample. 
Molecular weight of DNA fragments of FABP modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 4963 m/z at 0s corresponds to the FABP modified 16-
mer dC template. 2876 m/z corresponds to the modified lesion site of G3 (b) 5’ digestion 
profiles of 4963 m/z ion at 0 s shows the whole sequence and 2830 m/z peak corresponds 
to the fragment near the lesion G3, 2540 m/z  peak indicates the G3 lesion site. Both 3’ 
and 5’ digestions show peak 2 as G3.  
Figure 16: MALDI spectra of 3’ and 5’ enzyme digestions of FABP dC peak 3 sample. 
Molecular weight of DNA fragments of FABP modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 4963 m/z at 0s corresponds to the FABP modified 16-
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mer dC template. 2258 m/z corresponds to the modified lesion site of G2 (b) 5’ digestion 
profiles of 4963 m/z ion at 0 s shows the whole sequence and 3776 m/z peak corresponds 
to the fragment near the lesion G2, 3159 m/z  peak indicates the G2 lesion site. Both 3’ 
and 5’ digestions show peak 3 as G2.  
Figure 17: MALDI spectra of 3’ and 5’ enzyme digestions of FABP dT peak 1 sample. 
Molecular weight of DNA fragments of FABP modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 4980 m/z at 0s corresponds to the FABP modified 16-
mer dT template. 1930 m/z corresponds to the modified lesion site of G1 (b) 5’ digestion 
profiles of 4980 m/z ion at 0 s shows the whole sequence and 3504 m/z  peak indicates 
the G1 lesion site. Both 3’ and 5’ digestions show peak 1 as G1.  
Figure 18: MALDI spectra of 3’ and 5’ enzyme digestions of FABP dT peak 2 sample. 
Molecular weight of DNA fragments of FABP modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 4980 m/z at 0s corresponds to the FABP modified 16-
mer dT template. 2878 m/z corresponds to the modified lesion site of G3 (b) 5’ digestion 
profiles of 4980 m/z ion at 0 s shows the whole sequence and 2844 m/z peak corresponds 
to the fragment near the lesion G3. Both 3’ and 5’ digestions show peak 2 as G3.  
Figure 19: MALDI spectra of 3’ and 5’ enzyme digestions of FABP dT peak 3 sample. 
Molecular weight of DNA fragments of FABP modified fragments listed in the inset 
boxes. (a) 3’ digestion profiles of 4980 m/z at 0s corresponds to the FABP modified 16-
mer dT template. 2259 m/z corresponds to the modified lesion site of G2 (b) 5’ digestion 
profiles of 4980 m/z ion at 0 s shows the whole sequence and 3505 m/z peak corresponds 
to the fragment near the lesion G2, 3175 m/z  peak indicates the G2 lesion site. Both 3’ 
and 5’ digestions show peak 3 as G2. 
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Figure 20: UV thermal melting curves for four TLS models of FAAF modified 
sequences. (a) dC series (b) dT series.   
Figure 21: UV thermal melting curves for four TLS models of FABP modified 
sequences. (a) dC series (b) dT series.   
Figure 22: Thermal and thermodynamic parameters from UV overlay of  FAAF dC 
sequence based on the increment of primers, left side is the comparison of  sequence with 
full length primer and right side is comparison of sequence with -2 deletion primers; (a) 
comparison of melting temperature (b)comparison of -ΔG change. Blue is unmodified 
control and red is FAAF modified.  
Figure 23: Thermal and thermodynamic parameters from UV overlay of  FAAF dT 
sequence based on the increment of primers, left side is the comparison of  sequence with 
full length primer and right side is comparison of sequence with -2 deletion primers 
(a)comparison of melting temperature; (b)comparison of -ΔG change. Blue is unmodified 
control and red is FAAF modified.  
Figure 24: Thermal and thermodynamic parameters from UV overlay of  FABP dC 
sequence based on the increment of primers, left side is the comparison of  sequence with 
full length primer and right side is comparison of sequence with -2 deletion primers; (a) 
comparison of melting temperature (b) comparison of -ΔG change. Blue is unmodified 
control and red is FABP modified.  
Figure 25: Thermal and thermodynamic parameters from UV overlay of  FABP dT 
sequence based on the increment of primers, left side is the comparison of  sequence with 
full length primer and right side is comparison of sequence with -2 deletion primers: (a) 
comparison of melting temperature (b) comparison of -ΔG change. Blue is unmodified 
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control and red is FABP modified.  
Figure 26: DSC curves of FAAF recorded from 15 °C to 85 °C. (a) dC unmodified 
template with -2 deletion primers (b) dC G3 FAAF modified sequence with -2 deletion 
primers (c) dT unmodified template with -2 deletion primers (d) dT G3 FAAF modified 
sequence with -2 deletion primers.  
Figure 27: CD spectral overlays of G3-FAAF/FABP-modified sequence in three -2 
deletion duplex forms. (a) dC and (b) dT with primers of n-1, n, n+1 at 25ºC. Green dot: 
with n primer; blue line: with n-1 primer; red dot: with n+1 -2 deletion primer.  
Figure 28: CD spectral overlays of G3-FAAF-modified sequence (red) with unmodified 
sequence control (blue) in -2 deletion models. (a) dC and (b) dT with primers of n-1, n, 
n+1, n+2,n+3 and n+6 at 25ºC.  
Figure 29: CD spectral overlays of G3-FABP-modified sequence (red) with unmodified 
sequence control (blue) in -2 deletion models. (a) dC and (b) dT with primers of n-1, n, 
n+1, n+2,n+3 and n+6 at 25ºC.  
Figure 30: Dynamic 
19
F NMR spectra of dC G3- FAAF template paired with -2 del 
primers (n-1, n, n+1, n+3, n+6) from 5 to 70 °C. 
Figure 31: Dynamic 
19
F NMR spectra of dT G3- FAAF template paired with -2 del 
primers (n-1, n, n+1, n+3, n+6) from 5 to 70 °C. 
Figure 32: Imino proton NMR spectra of dC G3- FAAF template paired with -2 del 
primers (n-1, n, n+1, n+3, n+6) from 5 to 60 °C.  
Figure 33: Imino proton NMR spectra of dT G3- FAAF template paired with -2 del 
primers at (n-1, n, n+1, n+3, n+6) from 5 to 60 °C. 
Figure 34: Simulation of FAAF modified dC/dT duplexes from n-1 to n+6 at 20 °C. 
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Conformer populations show in %.  
Figure 35:  Dynamic 
19
F NMR of FABP modified G3 of dC series along with -2 deletion 
primers from 5 to 70 °C.  
Figure 36:  Dynamic 19F NMR of FABP modified G3 of dT series along with -2 deletion 
primers from 5 to 60 °C.  
Figure 37: Imino proton NMR sepctra of FABP modified G3 of dC series along with -2 
deletion primers from 5 to 60 °C.  
Figure 38:  Imino proton NMR sepctra of FABP modified G3 of dT series along with -2 
deletion primers from 5 to 60 °C.  
Figure 39:  Mechanism of FAAF/FABP modified NarI sequence forming the bulge 
structure during the TLS.  
Figure 40:  HPLC chromatography profiles of FAAF modified 5’-biotin-NarI-sequence. 
(a) dC sequence; mono-adducts eluted between 12-14 min  (b) dT sequence mixture, 
mono-adducts eluted between 13-18 min.  
Figure 41:  HPLC chromatography profile of FABP modified 5’-biotinylated dC 
sequence. Mono-adducts eluted between 45-53 mins.  
Figure 42: 3’ SVP digestion of FAAF modified biotin dC/dT monoadduct Peak 2. (a) dC 
sequence, 5424 m/z ion at 0 s corresponds to the FAAF modified 5’-Biotin-16-mer dC 
template. The 3915 and 3625 m/z peaks correspond to the fragments near the lesion; the 
digestion stopped at 3336 m/z peak shows the G3 modified site (b) dT sequence, 5439 
m/z at 0 s corresponds to FAAF modified 5’-biotin-16-mer dT template. The 3625 and 
3336 m/z peaks suggest the G3 modified site. 
Figure 43: 3’ SVP digestion of FABP modified biotin dC/dT monoadduct Peak 2. (a) dC 
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sequence, 5370 m/z ion at 0 s corresponds to the FABP modified 5’-Biotin-16-mer dC 
template. The 3282 m/z peak corresponds to the fragments at G3 modified site. (b) dT 
sequence,  5383 m/z at 0s corresponds to FABP modified 5’-biotin-16-mer dT template. 
The 3283 m/z peak suggests the G3 modified site.  
Figure 44: SPR sensorgrams of FAAF four stimulated models from n-1 to  n+8/n+6 in 
dC/dT series. (a) dC unmodified in full length model (b) dT unmodified in full length 
model (c) dC FAAF modified in full length model (d) dT FAAF modified in full length 
model (e) dC unmodified in -2 SMI model (f) dT unmodified in -2 SMI model (g) dC 
FAAF modified in -2 SMI model (h) dT FAAF modified in -2 SMI model. 
Figure 45: SPR sensorgrams of FABP four stimulated models from n-1 to n+8/n+6 in 
dC/dT series. (a) dC unmodified in full length model (b) dT unmodified in full length 
model (c) dC FABP modified in full length model (d) dT FABP  modified in full length 
model (e) dC unmodified in -2 SMI model (f) dT unmodified in -2 SMI model (g) dC 
FABP modified in -2 SMI model (h) dT FABP modified in -2 SMI model.  
Figure 46: Normalized SPR sensorgrams of FAAF modified four stimulated models at n, 
n+1, n+2, n+3 and n+8/n+6 position in (a) dC series; (b) dT series.  
Figure 47: Normalized SPR sensorgrams of FABP modified four stimulated models at n, 
n+1, n+2, n+3 and n+8/n+6 position in (a) dC series; (b) dT series.   
Figure 48: Dissociate rate constant (kd) simulated SPR sensorgrams of four different 
models with FAAF fitted by scrubber. Red lines are fitted and black is raw data. (a) dC 
series (b) dT series.  
Figure 49: Dissociate rate constant (kd) simulated SPR sensorgrams of four different 
models with FABP fitted by scrubber. Red lines are fitted and black is raw data. (a) dC 
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series (b) dT series.  
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Table legends 
Table 1:  Thermal and thermodynamic parameters of G3- FAAF-modified dC duplexes
 
from UV melting  
Table 2:  Thermal and thermodynamic parameters of G3- FAAF-modified dT duplexes
 
from UV melting  
Table 3:  Thermal and thermodynamic parameters of G3- FABP-modified dC duplexes 
from UV melting
 
Table 4:  Thermal and thermodynamic parameters of G3- FABP-modified dT duplexes 
from UV melting
 
Table 5:  Thermal and thermodynamic parameters of G3- FAAF-modified dC/dT 
duplexes from DSC  
Table 6:  Blue shift comparison between FAAF/FABP modified sequence and 
unmodified control in -2 SMI model 
Table 7: The dissociate rate constant (kd, s
-1
) of individual primer in FAAF modified 
sequence 
Table 8: The dissociate rate constant (kd, s
-1
) of individual primer in FABP modified 
sequence 
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Appendix 
Published in Nature Protocol Exchange, 2013, doi:10.1038/protex.2013.054 
 
Binding kinetics of DNA-protein interaction using surface plasmon 
resonance 
V.G. Vaidyanathan, L. Xu and Bongsup P. Cho
* 
 Surface plasmon resonance (SPR) has been used extensively in the field of 
DNA/DNA, DNA/protein, and small molecule protein/DNA interactions. However, there 
have been growing concerns with regard to the proper designing of experiments and the 
quality of analysis and reporting of SPR results (1). Here we describe a protocol that is 
designed to address some of those issues. It encompasses procedural steps beginning with 
immobilization of streptavidin on CM5 chips to the final step of data reporting on DNA-
polymerase interaction binding kinetics. In evaluating the protocol, we carried out 
experiments using a simple methodology developed in our laboratory, taking advantage 
of the high sensitivity and superior signal-to-noise ratio of Biacore T200. We probed the 
binary and ternary binding affinities between exonuclease-deficient Klenow fragment 
(Kf-exo
-
) and various arylamine DNA lesions. We employed unmodified and carcinogen-
modified oligonucleotides in the presence and absence of dNTPs.  The total time required 
to carry out the method to completion is between one and two weeks, approximately two 
days for the SPR binding assays and one week for synthesis, purification, and 
characterization of modified oligonucleotides. Though the protocol presented here is 
meant for Biacore T100 or T200 model, the overall methodology can be applied for other 
instruments also. 
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Reagents 
CM5 sensor S chip (Research grade, cat. No. BR-1005-30)  
HBS-EP+ (10X containing 0.1 M HEPES, 1.5 M NaCl, 30 mM EDTA and 0.5% v/v 
Surfactant P20) (GE Healthcare, cat. No. BR-1001-88) 
Streptavidin (Piercenet, cat. No. 21125) 
HBS-P+ (10X containing 0.1 M HEPES, 1.5 M NaCl, and 0.5% v/v Surfactant P20)(cat. 
No. BR-1003-68) 
Formamide (Sigma-Aldrich, cat. No. F7508) 
Amine coupling kit (GE Healthcare, cat. No. BR-1000-50) 
Bromophenol blue (Sigma-Aldrich, cat. No. B0126)  
EDTA (EMD Biochemicals, cat. No. 4055-100ML)  
Tris/NaCl (Fisher Scientific, cat. No. BP2478-500)  
T4 DNA ligase and ligase buffer (New England BioLabs, cat. No. M0202S)  
Sigmacote (Sigma Aldrich, cat. No. SL2)  
Bovine Serum from Albumin (Sigma, cat. No. A9418)  
40%, 19:1 Acrylamide/Bis (Bio-Rad, cat. No. 161-0144)  
TBE (Promega, cat. No. V4251)  
Urea (Fisher Scientific, cat. No. 104924)  
Ammonium persulfate (APS) (Sigma, cat. No. A3426) 
TEMED (Fisher BioReagents, cat. No. BP150-100)  
10% glycerol (Sigma-Aldrich, cat. No. G5516)  
ddTTP (GE Healthcare, cat.No. 27-2045-01)  
Magnesium chloride (Fisher Scientific, cat. No. M8266)  
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Sodium acetate (Sigma-Aldrich, cat. No. S8750) 
3-Hydroxypicolinic acid (3-HPA) (Fluka analytical, cat. No. 56197) 
Ammonium citrate dibasic (MP, Biomedicals, cat. No. 152494)  
Tris/EDTA (Fisher Scientific, cat. No. BP2475-1) 
n-Butanol (ACROS, cat. No. 42349-0010) 
Phenol: Chloroform: Isoamyl acohol (25:24:1, v/v) (Invitrogen, cat No. 15593-031) 
Chloroform (Pharmco-AAPER, cat No. 309000000) 
DNA (Eurofins)  
Kf-exo
-
 (gift from Dr. Catherine Joyce at Yale University) 
 
Equipments 
Biacore T200 SPR instrument (GE Healthcare) 
MALDI-TOF spectrometer (Axima Performance, Shimadzu Biotech) 
Sequencing gel apparatus (Bio-Rad) 
Centrifuge (Eppendorf, 5414 D) 
Speedvac (ThermoSavant, model: SPD 2010-220) 
HPLC instrument (Hitachi LaChrome Elite L2400 series) 
Spectrophotometer (Eppendorf) 
Dry bath (Isotemp, Fisher Scientific)  
 
Procedure (Duration: 5 days) 
Sample preparation  
Day 1: 
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A. Preparation of 5-Biotin-DNA-83 mer Ligation 
1. DNA annealing: Mix 5-Biotin-DNA 31 mer (unmodified or modified) and 52 
mer hairpin DNA (1:1.5) ratio in 10 mM Tris/50 mM NaCl buffer and heat to 95C for 5 
min and cool down slowly to room temperature (approx. 2-3 h). 
2. Dry the sample in Speedvac and dissolve it in 25 L deionized water and desalt it 
using Illustra G-25 spin columns. 
3. To the desalted solution, add 3 L T4 DNA ligase buffer (10 x), add T4 DNA 
ligase 2.5 L (2000 U/L) and 19.5 L deionized water and incubate at 20C for 16 h. 
4. Centrifuge and add 20 L loading dye (consists of 50 L 0.5 M EDTA/ 950 L 
formamide), heat it to 95C for 5 min; cool it down using ice-bath. 
B. Purification of oligonucleotides (83 mer) by using 10% denaturing gel  
5. Mix 40% acrylamine/ Bis 17.5 mL, 10 x TBE 7mL, urea 29 g in 39.5 mL 
deionized water in a conical flask and dissolve the mixture. 
6. Wipe either outer or inner plate with Sigmacote. (Critical step: Don’t wipe 
Sigmacote on both plates). 
7. Setup the glass plates, cast the gel after adding 200 L APS (30% w/v) and 100 
L TEMED to the acrylamide solution (step 5) and leave it for 30-45 min to solidify. 
8. After removing the comb, flush the wells with the running buffer (1 x TBE) to 
remove the residual urea.  
9. Pre-run the gel at 2,000 V for 30 min. 
10. Load the DNA samples and run the gel at 2,000 V for 2-3 h. 
11. After completion of the run, cool down the gel with cold water and pry the gel 
plates quickly. 
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12. Cover the gel with saran wrap, peel the gel and expose over the TLC plate. 
13. Cut desired ligated oligonucleotide bands by exposing under short wavelength 
UV and transfer to a microcentrifuge (1.5 mL). 
14. Crush the gel using micropipette tip. 
15. Add 1 mL 1x TE buffer and keep in the -80 C refrigerator for 10 min, heat it at 
95 C for 5 min; centrifuge and collect the supernatant. 
16. Repeat step 15 for three times and pool the supernatant into one. 
17. Add 1 mL 1 x TE buffer to the crushed gel, incubate at 37 C overnight and 
centrifuge and merge the supernatant with step 16.  
Day 2: 
18. Filter the pooled solution using 0.2 m filter.  
19. Reduce the volume to 0.2 mL by extracting with n-butanol. 
20. Add 200 L Phenol: Chloroform: Isoamyl alcohol (25:24:1, v/v), vortex, 
centrifuge and discard the organic layer. 
21. To the aqueous solution add 200 L chloroform and vortex, discard the organic 
layer. 
22. Add 20 L sodium acetate (pH 5.2, 3 M), 80 L deionized water and 1.2 mL 
100% ethanol, freeze it in -80 C for 30 min. 
23. Centrifuge the sample at 13,000 rpm for 30 min and remove the supernatant. 
24. Add 100 L 70 % ethanol, centrifuge for 5 min, remove the supernatant and dry it 
in speedvac. 
25. Dissolve the white precipitate in 25 L deionized water and desalt it using spin 
column. 
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C. Preparation of 5-Biotin-DNA-84 mer  
26. Mix 1 L Klenow fragment-exo-  (Kf-exo-) with 4 L dilution buffer (50 mM 
Tris/ 10% glycerol/ 100 g/ml BSA), 1 L ddTTP (100 mM), 10 L MgCl2 (5 mM), Tris 
(50 mM) to 5-Biotin-DNA 83 mer (in 10:1 ratio, Kf-exo-: DNA), incubate at 37 C 
overnight. 
Day 3: 
27. Repeat steps 20-25. 
28. Purify the oligonucleotides using RP-HPLC, Clarity column (pore size 3 m, 
Oligo-RP 50  4.6 mm, cat. No. 00B-4441-E0) in the mobile phase (ammonium acetate 
and acetonitrile), linear gradient: 3% acetonitrile increase to 7% in 5 min, 17% 
acetonitrile in 20 min, 22% acetonitrile in 25 min.   
29. Lyophilize the samples and measure the OD at 260 nm. 
D. Characterization of oligonucleotides using MALDI-TOF 
Setting up Calibration file for linear negative mode (for MW > 10,000 Da) 
30. HPLC purified 52 mer hairpin DNA (MW 15,161 Da), 80 mer (MW 24,293 Da), 
90 mer (MW 27,431 Da) and 100 mer DNA (MW 30,496 Da) are used as calibration 
standards. 
31. Prepare the standard MALDI samples by mixing 1 L of standard (100 pmol) 
with 1 L 3-HPA (50 mg/mL in acetonitrile: water 1:1 v/v) and 1 L ammonium citrate 
dibasic (50 mg/mL, water). 
32. Spot the standards (1 L) on MALDI steel plate (model DE 1580 TA). 
33. Dry the sample spots and insert the plate in the MALDI instrument. 
34. Choose the linear negative tuning mode, molecule range 5,000-32,000, firing 
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power 120, profiles 200, and shots 100, pulsed extraction optimized at 30,000 Da.                                                                                                                                                                                              
35. In the calibration window, enter 4 standards' mass and name. 
36. Fire one standard a time, place the cursor to the required peak and update in the 
calibration window. 
37. Repeat this step to finish the rest of the standards, and click the “Calibrate” button 
twice.  
38. Save the calibration method in the calibration files.  
For characterization of 31, 83, 84 mer 5’-Biotin-DNA  
39. Mix 100 pmol oligonucleotide with 1L 3-HPA and 1 L ammonium citrate 
dibasic; spot it on MALDI plate. 
40. Choose linear negative mode, molecule range 5000-30,000, firing power 100-120, 
profiles 200, shots 100, pulsed extraction optimized at 30,000 Da. 
41. Load the linear negative calibration profile. 
42. Start firing 83 and 84 mer samples. 
43. For 31 mer DNA (MW < 10,000 Da), linear negative mode is not applicable 
because of large signal to noise ratios, reflectron positive mode and peptide calibration 
profile can be used.  
44.  In the peak processing part, advanced scenario is used, along with 1 channel peak 
width, average smoothing method, 20 channels smoothing filter width, subtract the 
baseline, 80 channels of baseline filter width, 25 % Centroid threshold peak detection 
method, double threshold, 1 mass range. 
Day 4 
Step 1: Immobilization of Streptavidin 
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Open > New Wizard Template > Immobilization 
45. Select Chip type CM5. 
46. Check immobilize flow cells (1, 2) or (1, 2, 3, 4) (keeping 1, 3 as blank and 2,4 
are samples). 
47. Flow cell 1: Method: Amine; Check specify contact time and flow rate: Contact 
time: 420 s; Flow rate: 10 L/min. 
48. Flow cell 2: Method: Amine; Ligand: Streptavidin; Dilute ligand: Uncheck (if it 
is already diluted); Check specify contact time and flow rate: Contact time: 420 s; Flow 
rate: 10 L/min. 
49. Prime before run (check if it is not primed before). 
50. Analysis temperature: 25  C. 
51. Sample compartment temperature: 25  C. 
52. For immobilizing flow cell 1: EDC: 89 L; NHS: 89 L; Empty vial; 
Ethanolamine: 129 L. 
53. For immobilizing flow cell 2: EDC: 89 L; NHS: 89 L; Empty vial; 
Ethanolamine: 129 L; Streptavidin: 98 L. 
54. Choose menu >Automatic positioning > Pooling > Auto. 
55. Keep running buffer in left tray and insert buffer tubing A (In this step, running 
buffer: 100 mL 1 x HBS-EP
+
 buffer; but varies in DNA binding kinetics). 
56. Keep fresh deionized water (200 mL) in right tray. 
57. Empty the waste bottle. 
58. Save the wizard (save as ….). 
Step 2: DNA coating 
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59. Choose Run > Manual run > select the flow path: 1, 2.   
60. Flow rate: 2 L/min and select the appropriate rack. 
61. Inject 50 mM NaOH 60 s pulse for 5 times till the drop in response unit before 
and after injection of NaOH lies between 10 and 20 RU. 
62. Inject 1 x HBS-EP+ buffer for 3 times (1 min pulse). 
63. Leave the chip for 30 min to 1 h depending on the baseline drift. 
64. Select the channel to flow cell 2 (Critical step: Don’t forget to change the flow 
cell to 2 otherwise biotin-DNA will be coated in flow cell 1 also and it is difficult to 
remove the biotin-DNA). 
65. Critical step: Inject biotinylated DNA (0.25 or 0.3 nM) for 1 min and stop the 
injection after 30 s.  
66. Critical step: Check the rise in the response unit. If it goes beyond 5 RU with in 
30 s, dilute the sample.  
67. Critical step: Increase in response should be between 0.5 and 3 RU. Leave it for 
15 min to see any drift in baseline.  
68. Change the buffer to 1 x HBS-P+/ 100 ug/mL BSA/ 5 mM MgCl2. Prime the 
system.  
69. To ensure the hairpin-oligonucleotide contains 5’-dideoxy base, inject the sample 
containing Kf-exo
-
+ 100 mM ddTTP + 1 x HBS-P
+
/ BSA/ 5 mM MgCl2 buffer for 5 min.  
70. Inject 0.05% SDS for 240 s (2 L/min flow rate) and inject running buffer for 5 
min. Now the surface is ready for further studies. 
Step 3: Regeneration scouting 
71. Select the flow path and chip type.  
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72. Choose number of regeneration buffer set (either 1 or 2). 
73. Run conditioning cycles with buffer (1 x HBS-P+/ BSA/ 5 mM MgCl2 for 30 s 
and 3 injections). 
74. Sample name (Prepare Kf-exo- (5 nM)). 
75. Contact time: 30 s and flow rate: 100 L/min. 
76. Scouting parameters: Flow rate: 100 L/min; Contact time: 30 s; Stabilization 
period; 300 s; Number of conditions: 3; Number of cycles for each condition: 5 ; Lock: 
contact time; Provide names for each regeneration buffer: (0.1% SDS; 0.05% SDS; 1M 
NaCl in this case). 
77. Repeat steps 54-58. (Critical step: Check the binding response and baseline drift 
of all the cycles.) (Critical step: Running buffer: 1 x HBS-P
+
/ 100 ug/mL BSA/ 5 mM 
MgCl2) 
Step 4: Surface performance 
78. Repeat steps 72-75. ( Flow rate: 100 L/min; Contact time: 30 s; Stabilization 
period: 300 s; Number of conditions: 3; Number of cycles: 20) 
79. Select the best regeneration buffer from previous assay (regeneration buffer 
scouting). 
80. Repeat steps 54-58. (Critical step: Check the binding response and baseline drift 
of all the cycles.) 
Step 5: Mass transport  
81. Repeat steps 72-75. 
82. Choose regeneration: Solution: 0.05% SDS (in this case); Contact time: 30 s; 
Flow rate: 100 L/min and Stabilization period: 300 s. 
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83. Input Sample Id; (either one or more samples of different concentrations). Rate 
should be independent of flow rate (Figure 1). 
84. Repeat steps 54-58. 
Day 5: 
Step 6: Kinetics 
85. Repeat steps 72-75. 
86. Injection parameters: Contact time: 30 s; Flow rate: 100 L/min; Dissociation 
time: 60 s; Regeneration solution: 0.05% SDS; Contact time: 30 s; Flow rate: 100 
L/min; Stabilization period: 300 s. 
87. Input sample id; concentration; molecular weight etc. (Critical Step: At least 
each concentration of analyte should be injected in duplicate or triplicate and in random.) 
88. Repeat steps: 54-58. 
Step 7: BIAevaluation 
89. Choose kinetics/Affinity > Surface bound. 
90. Select the curves to fit. 
91. Zoom the curves to remove the spikes by right click and drag. 
92. Select kinetics or affinity to fit the data. 
93. Select the model to fit. (start with 1:1) 
94. Check the kinetic data in tools. 
95. Critical Step: As the modification factor (M) sliding bar varies, blue and red 
lines (rate constants increase or decrease) should vary. Otherwise data is limited by mass 
transport (Figure 2). 
96. Critical Steps: Check the following parameters 
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i. How well does the fitted curve overlay with the experimental data. 
ii. Does the random injection of same concentration of analyte overlay. 
iii. Check the residual range (between the green lines in Biaevaluation software). 
iv. Does 2 fall within 1% of highest signal response. 
v. Does ka and kd values fall within instrument specification and check whether it 
makes any biological significance.Make sure T values are significant. For ka and kd, T 
values should be higher and kt values, it should be as minimum as possible. 
vi. Mass transport limitation: Check whether data is limited by mass transport (step 
96). 
vii. Check the U value (this feature present in Biacore T200 not in T100). 
Step 8: BIAsimulation 
97. Once ka and kd values are determined, input these parameters in BIAsimulation 
Basic kinetics module.  
98. Compare the curves between simulated and experimental curves (Figure 3). 
Step 9: Preparation of reports 
99. The fitted curves can be plotted by exporting the file in ASCII format by right-
click over the curves and imported it in any plotting software. 
 
Anticipated results 
Due to the high sensitivity of Biacore T200, the DNA coated on the surface and 
polymerase used in this study was as low as 0.7-3.5 RU and 10 nM, respectively. The 
amount of DNA and polymerase required for this assay is 20-100 fold lower than that 
required by previously reported methods(2).  With low DNA concentration potentially 
confounding complexities of mass transport limitation could be minimized and possibly 
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avoided.  In this protocol, hairpin-DNA was used to achieve additional stability as well as 
to overcome the likelihood of presence of single-stranded template alone which may 
complicate in obtaining accurate kinetics parameters. 
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Figure legends 
Figure 1: Effect of mass transport limitation. (a) Rate varies with the flow rate (5, 15, 75 
L/min) of Kf-exo- due to high DNA surface density (b) Rate is independent of flow rate. 
Figure 2: Binding kinetics of polymerase to DNA affected by mass transport. Red circles 
show the modification factor M at maximum value 10. The original data is in black; the 
blue curves are simulated ka and kd multiplied by M; the red show the simulated ka and kd 
divided by M. The divergence of red and blue curves will be observed in no mass transfer 
case. (a) and (b) kinetics data completely affected by mass transfer as the modification 
factor varies (c) No mass transfer. 
Figure 3: Binding kinetics of polymerase with DNA.  (a) Experimental and fitted data in 
black and red, respectively. (b) Simulated data for various concentrations using the k
a
 and 
k
d
 values (k
a
:  9.210
7
 M
-1
s
-1
; k
d
: 0.12 s
-1
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